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GENERAL INTRODUCTION 
Mycotoxins are fungal metabolites that possess diverse 
properties which could be used in fermentation, food 
flavorings, and antibiotics. Some mycotoxins cause plant, 
human, and animal diseases. Thus, their control is of 
considerable economic and social importance. Mycotoxins are 
ubiquitous in nature, with their contamination of foodstuffs 
recognized for decades as a problem. "Turkey X" disease 
caused by aflatoxin B, (AFB^) , a mycotoxin produced by A. 
flavus, was first reported about 30 years ago (Sargeant et 
al., 1961); AFB^ is a potent natural hepatocarcinogen. 
Fumonisins, mycotoxins from Fusarium moniliforme and Fusarium 
proliferatum, are also gaining reputation as other natural 
hepatocarcinogens, but their mode of action has yet to be 
determined. 
Fumonisins have been implicated in disease outbreaks 
causing brain disease in horses in the U.S.A. (Marasas et al., 
1988). They are present in high concentrations in maize used 
as a staple food in the Transkei, South Africa, an area 
characterized by one of the world's highest rates of human 
esophageal cancer (Sydenham et al., 1990). Successful 
isolation and characterization of fumonisins has made it 
possible to determine their possible health effects on human 
and animals. Most research has shown that fumonisins are 
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hepatotoxic as well as hepatocarcinogenic to male rats 
(Gelderblom et al., 1991). However, it has not been 
established that this also applies to female rats. The gender 
difference is important in carcinogenesis because there is 
often a sex-dependence in the ability of chemicals to induce 
cancer (Demi and Oesterle, 1982). Thus, this research will 
examine hepatocarcinogenesis in females due to F. proliferatum 
mycotbxins. Numerous preneoplastic markers of enzyme altered 
foci (EAF), sometimes referred to as altered hepatic foci 
(AHF), are used in carcinogenesis to quantify the effects of 
initiating or promoting agents. So far, only one marker viz., 
^-glutamyl transferase (GGT), has been used to quantify the 
effects of fumonisins as hepatocarcinogens. The second 
objective of this research is to study the 
hepatocarcinogenicity of fumonisin B1 using placental 
glutathione S-transferase (PGST) marker. 
There is a positive relationship between carcinogenic and 
teratogenic chemicals and, since FB, is a carcinogen in rat 
liver, it may also be a teratogen. Aflatoxin is a 
hepatocarcinogen as well as a teratogen in a variety of animal 
species. The third objective is to determine the teratogenic 
potential of FB^ in rats. 
Research is still lacking in various areas such as the 
metabolism, biosynthesis and mode of action of fumonisins. 
But in order to address these questions it is imperative to 
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develop a suitable substrate medium that will allow production 
of labelled fumonisins in significant quantity. Fumonisin 
production from a solid substrate (corn) is very easy, but the 
isolation and purification processes are tedious and 
expensive. Therefore, it is important to develop a liquid 
medium that would support production of efficiently labelled 
fumonisins.. Thus, the fourth objective of this research is to 
develop a liquid medium that would produce fumonisins in 
sufficient quantities that could be used for metabolism 
studies. 
Explanation of dissertation format 
This dissertation is composed of three papers. The first 
two are modified manuscripts formatted for publication in 
Carcinogenesis and Journal of Food and Chemical Toxicology, 
respectively. The third paper will also be submitted to a 
technical journal as yet undetermined. Each paper has its own 
abstract, introduction, material and methods, results, 
discussion and bibliography. Following the three papers is a 
general summary of the entire dissertation. References cited 
for the general introduction and literature review follow the 
general summary. 
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LITERATURE REVIEW 
Hycotoxins 
Mycotoxins are secondary metabolites produced by fungi. 
They are produced by a large number of fungi contaminating 
diverse foods and commodities. Aspergillus^ Fusarium and 
Pénicillium genera are the major mycotoxin-producing fungi 
that contaminate foods. Stress factors such as water, 
temperature, and insect damage of the host plant determine the 
fungal infestation and ultimate production of the mycotoxin. 
Mycotoxins have chemically diverse structures, thus their 
biological activities differ greatly. One fungal species can 
produce a variety of chemically diverse mycotoxins, e.g., 
moniliformin, fumonisins, fusarin, etc., are produced by F. 
moniliforme and F. proliferatum. A particular mycotoxin might 
also be produced by a variety of species or genera, e.g., 
tricothecenes are produced by Fusarium, Cephalosporium, 
Myrothecium, Stachybotrys and Trichoderma. Mycotoxins can 
display specific organ toxicity (e.g., ochratoxin A - a 
nephrotoxin), and can be mutagenic, carcinogenic and/or 
teratogenic (CAST, 1989). 
Mycotoxin-associated diseases have long been known to 
occur. Ergotism, caused by a toxin from Claviceps purpurea, a 
fungus that contaminated rye, was the earliest disease 
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reported. Disease epidemics such as alimentary toxic aleukia 
(ATA), caused by tricothecenes from Fusarium, occurred around 
World War II in the Soviet Union (Marasas and Nelson, 1987). 
Several mycotoxins considered to be of human or animal health 
concern are cited in the literature (CAST, 1989; Marasas and 
Nelson, 1987). Aflatoxins are the most studied and the only 
regulated mycotoxins in the U.S.A. Fumonisins, mycotoxins 
isolated from F. moniliforme and F. proliferatum, are newly 
described mycotoxins (Gelderblom et al., 1988a). Because of 
their predominance in several food commodities such as corn, 
sorghum, and millet (Nelson et al., 1991), and their toxic 
effects on animals as well as possible health risks to human, 
the Food and Drug Administration-USDA Interagency Working 
Group on Fumonisins is considering their regulation in the 
near future (Hansen, 1993). Although clear-cut toxicity of 
many mycotoxins to humans has not been demonstrated, the 
effects of these compounds on experimental animals and in 
vitro leaves little doubt about their potential toxicity to 
humans. 
Mycotoxins as teratogens 
There is sparse evidence concerning the toxicity of 
mycotoxins to embryonic development because most research has 
been done on adult animals. The importance of mycotoxins in 
reproduction may be indirect; i.e., they may reduce fertility 
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by having effects on parental gametogenesis. For example, 
zearalenone, a metabolite of Fusarium roseum, induces 
feminization syndrome in male pigs and hyperestrogenism in 
female pigs (Hayes, 1981). Mycotoxins may also affect 
intrauterine development by causing toxic effects on the vital 
maternal organs such as liver, kidneys and the immune system, 
thus impairing maternal health. Invariably, poor maternal 
health may result in inefficient nutrient transfer, and 
increased xenobiotic transfer to the developing fetus 
(Abramovici, 1977). Depending on the metabolism, mycotoxins 
may be transferred as electrophilic metabolites after 
detoxification by the mother, thus impairing fetal development 
(Abramovici, 1977). Depending on the dosage and gestation 
period, mycotoxins may also impair fetal development by 
inducing abortions or inducing variable malformations in the 
fetuses. 
Teratogenic effects of other Fusarium mycotoxins besides 
zearalenone have been documented in experimental and farm 
animals. Fusarenon-X fed to mice at 5, 10 or 20 ppm during 
gestation resulted in stunting and abortions either as a 
single or chronic dose (Hayes, 1981). Mycotoxins from 
Aspergillus and Pénicillium genera have also been shown to be 
teratogenic. Ochratoxin A (OA) was shown to cause mainly 
craniofacial anomalies, as well as other skeletal 
malformations (Arora & Frolen, 1981). Aflatoxin has also 
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been found to cause exencephaly, open eyes and protrusion of 
eyes in mice when dosed on day 7 of gestation (Arora et al., 
1981) . Aflatoxin B, has also been reported to cause fetal 
growth retardation when given to hamsters on day 8 of 
gestation by i.p. injection at 4 or 6 mg/kg (Schmidt & 
Panciera, 1980). 
Hycotoxins as carcinogens 
Carcinogenic mycotoxins, like chemical carcinogens, are 
biotransformed to DNA-adducts which ultimately result in 
genetic alterations. However, some carcinogens may not be 
genotoxic but are still capable of inducing neoplasia. Most 
mutagenic mycotoxins have also been found to be carcinogenic. 
Among carcinogenic mycotoxins, AFB^ has been studied 
extensively (Stark, 1980). Aflatoxin causes liver cancer 
in rats and trout at 20 ppb in diet fed for 12 months. There 
is also a greater than average prevalence of liver cell cancer 
(LCC) in humans in some Asian and African populations where 
high levels of AFB (3 - 222 ng/kg body weight) are ingested in 
foods. There is a positive association between high intakes 
of aflatoxins and incidence of LCC in these populations (CAST, 
1989). Carcinogenicity of other toxins from Fusaria species 
such as trichothecenes is still questionable (Wilson, 1982). 
The relationship between carcinogenesis and teratogenesis 
has been established for a variety of chemicals. The 
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relationship between the two processes is that they both 
involve rapid cell growth, therefore somatic cell division is 
a prerequisite for both. The critical distinguishing feature 
is that cancerous growth lacks organization while embryonic 
growth is well organized with each primordial cell destined to 
a particular function (Di Paolo and Kotin, 1966). Aflatoxin 
B1 and ochratoxin A are both teratogenic and carcinogenic to 
rats (CAST, 1989). 
Fusarium species 
Fusarium moniliforme is a fungus placed under section 
Liseola of the genus Fusarium. Species included in the 
section Liseola are F. moniliforme^ F. proliferatum, F. 
subglutinans and F. anthophilum. These species do not form 
chlamydospores, and are differentiated by the morphology of 
their macroconidia, such as shape (club or oval), and whether 
the conidia are borne in chains or false-heads (Nelson, 1992) . 
F. moniliforme is a common corn contaminant causing corn ear 
rot and kernel infections. It can cause corn diseases by 
systemic contamination (soil borne) or contamination of corn 
kernels during silking (Nelson, 1992). 
Fusarium moniliforme produces several metabolites among 
which fumonisins are the most predominant. Fusaric acid, 
produced by F. moniliforme and other Fusaria, affects plant 
cell respiration by inhibiting iron porphyrin oxidase (Nelson, 
9 
1992). Fusaric acid is also a chelator of metals such as 
copper, cobalt, and zinc (Bacon and Williamson, 1992). 
Fusarins are mutagenic metabolites of F. moniliforme which 
require activation by S-9 liver enzymes (Gelderblom et al., 
1988b; Lu et al., 1988). They are also very unstable, thus 
they are found in minute amounts in nature (Thiel et al., 
1986). Moniliformin is commonly produced by F. proliferatum 
and by very few isolates of F. moniliforme (Nelson, 1992). It 
is a highly toxic compound causing rapid death and intestinal 
and thymic hemorrhage when fed to rats at concentrations 
ranging from 3-8 mg/g of diet (Abbas et al., 1990). 
Fumonisins are mycotoxins recently isolated from Fusaria. 
They are produced predominantly by F. moniliforme and to a 
lesser extent by F. proliferatum (Ross et al., 1990) and F. 
nygamani (Thiel et al., 1991a). Fumonisins have been isolated 
mostly in corn products including human food, and in lesser 
quantities in sorghum and millet (Nelson et al., 1991; Murphy 
et al. 1993; Thiel et al., 1992). They have been 
characterized as diesters of propane-l,2,3-tricarboxylic acid 
and either 2-acetylamino- or 2-amino-12,16-dimethyl-3,5,14,15-
pentahydroxyicosane or its C-10 deoxy analogue. The first 
four fumonisins isolated were named fumonisin Al, A2, B1 and 
32 (Bezuidenhout et al., 1988); fumonisins B3 and B4 have also 
been reported (Cawood et al., 1991; Plattner et al., 1992). 
Their structure is similar to the tomato host-specific toxin. 
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the AAL toxin, produced by Alternaria alternata f. sp. 
lycopersici. This mycotoxin lacks one of the tricarboxylic 
acid side chains (Shier, 1993) . Fumonisin B1 is the most 
studied and it is produced in greater amounts than other 
fumonisins by most F. moniliforme strains. 
Under laboratory conditions, isolates of F. moniliforme 
cultures producing fumonisins have been successfully grown on 
corn, a solid medium substrate. Levels of about 6.4 g FB^/kg 
of corn were reported when the culture was grown for four 
weeks at room temperature (Nelson et al., 1991). Unsuccessful 
attempts have been made to produce high levels of FB^ in 
liquid cultures. The highest levels of fumonisins (140 ppm) 
produced from liquid cultures were from Alternaria alternata 
isolates (Chen et al., 1992), whereas only 74 ppm and 53 ppm 
FB^ have been produced from F. moniliforme isolates by Jackson 
and Bennett (1990) and Plattner and Shackelford (1992), 
respectively. Production of FB^ in liquid cultures will 
significantly facilitate the purification of fumonisins. 
Diseases resulting from fusarium mycotoxin infections, 
especially the trichothecenes, include chronic diseases such 
as eye, skin, subcutaneous and systemic infections (CAST, 
1989). Animal diseases implicating fumonisins have been 
documented as far back as 1850 in the midwestern states of the 
U.S.A. Similar outbreaks occurred again in 1930 and from 
1983-84 in the U.S.A. But it was only in the 1980s that 
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fuinonisins were isolated and implicated in disease outbreaks 
in horses. They cause leucoencephalomalacia in horses (Keller 
et al., 1990, Thiel et al., 1991b), pulmonary edema in pigs 
(Osweiler et al., 1992; Colvin et al., 1993), hepatocarcinoma 
in rats (Gelderblom et al., 1991), rickets in chicks (Brown et 
al., 1992), and have been implicated as a possible agent 
causing esophageal cancer in humans in Southern Africa 
(Rheeder et al., 1992). The atherogenic potential of 
fumonisins has been reported in vervets fed 0.25 - 1.0% of F. 
monilforme corn cultures in a high protein and low fat diet 
for 2 years. The corn culture materail was also hepatotoxic 
to the vervets (Fincham et al., 1992). The liver seems to be 
the common organ affected in pigs, horses and rats, although 
development of liver cancer has been reported in rats only 
(Gelderblom et al., 1991). Some feeding studies have reported 
renal toxicity in rats fed corn naturally contaminated with F. 
moniliforme from confirmed cases of ELEM (Voss et al., 1989). 
Fumonisins as hepatocarcinogens 
Several models used for inducing cancer in the rat liver 
have been identified (Farber, 1984). Some of these models 
have been employed in establishing whether fumonisins are 
complete or incomplete carcinogens. Gelderblom and associates 
(1988a) were able to demonstrate that the methanol-water 
(CHjOH-HjO) fraction containing FB^ fed for 4 weeks to male 
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rats, strain BD IX at 0.1% in diets for 1 week after DEN 
initiation induced significantly greater numbers of GGT-(+)AHF 
when compared to DEN initiated rats without FB,. Cancer 
promoting potential of other strains of F. moniliforme from 
corn in the Transkei (South Africa) were assayed using the 
initiation—promotion regimen. Fusarium moniliforme strains 
MRC 826 and MRC 4319 were found to be the most 
hepatocarcinogenic, inducing the most GGT-(+)AHF (Gelderblom 
et al., 1988b). 
Feeding purified FB, at 50 ppm incorporated into the diet 
for up to 26 months to BD IX male rats showed that FB^ is a 
complete carcinogen. Gamma-glutamyl transferase GGT-(+)AHF 
were induced. Hepatocellular carcinomas as well as metastases 
to the heart, lungs, or kidneys were noted (Gelderblom et al., 
1991). Chronic feeding of FB^ without prior initiation showed 
that FB, is a complete carcinogen. But most complete 
carcinogens are also initiators. Subsequent research by 
Gelderblom et al. (1992) on the cancer-initiating potential of 
fumonisins showed that they are poor initiators. To prove 
this, they employed two regimens for multistage 
carcinogenesis. The first regimen involved continuous feeding 
of FB^ at 0.1% in diets for 26 days, then exposure to a 
"selective agent" or promoter, namely, partial hepatectomy 
(PH), followed by 2-acetylaminofluorene (AAF) and/ or carbon 
tetrachloride (CCl^) in the diet. The other regimen involved 
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administration of varying doses (50 - 200 mg/kg) of fumonisins 
either as single or multiple doses to partially hepactomized 
male Fischer rats. Two weeks later, the rats were exposed to 
2AAF/CCI4 and killed 2 weeks after the promoting treatment. 
Rats that were fed FB^ for 26 days had greater number of GGT-
(+)AHF than the rats fed basal diets only. Selection of these 
AHF with 2AAF/CCI4 treatment after chronic exposure to FB^, 
produced a two-fold increase in the number of GGT-(+)AHF and a 
15 fold increase in the percentage area of foci/liver section 
compared to the rats fed FB for 26 days without PH nor 
2AAF/CCI4 treatment. Groups that were exposed to single or 
multiple doses of FB either before or after PH, had 
significantly lower number of GGT-(+) AHF than the 
diethylnitrosamine (DEN) positive control group, and the 
number of GGT-(+) foci were not significantly different from 
the negative control (group fed basal diet). Fumonisins 
failed to induce hyperplastic foci when fed as a single or 
discontinous dose indicating that fumonisins are poor cancer 
initiators, and are possibly promoters because neoplasia was 
induced with chronic feeding. 
The carcinogenicity of other fumonisins, and some of 
their derivatives, have been evaluated using a short-term 
carcinogenesis assay. During 21 days of feeding 0.1% 
fumonisins and their derivatives in the diet, male Fischer 
rats fed FBy, FB^ and FBj lost weight, and had GGT-(+)AHF after 
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the selection treatment. The data indicated that FBj was more 
toxic than FBg, while FBg was more toxic than FB^. All other 
derivatives (AFs and APs) were not toxic (Gelderblom et al., 
1993). Studies on the carcinogenicity of fumonisins indicate 
that fumonisins have both initiation and promotion 
capabilities when fed chronically. 
The mechanism of cancer induction by fumonisins in rats 
still remains to be explained since fumonisins are neither 
mutagenic in the Ames Salmonella test (Gelderblom and Snyman, 
1991) or genotoxic in the DNA repair assays in primary 
hepatocytes (Gelderblom et al., 1989). Moreover, they are 
poorly absorbed, and rapidly eliminated almost entirely in 
feces (Shephard et al., 1992). They have been found to alter 
sphingosine (SO)/sphinganine (SA) ratios in vitro (Wang et 
al., 1991). Alteration of SO/SA ratios in the liver, lungs 
and kidneys of pigs exposed to >23 ppm fumonisin B^ in the 
diet has also been reported (Riley et al., 1993). Assay of 
serum levels of sphingosine and sphinganine in horses dosed 
with 15 - 44 fig/g FB^ (Wang et al., 1992) and chicks dosed 
with 75 mg/kg FB^ in diet (Weibking et al., 1993) indicated a 
change in these sphingolipids before the onset of the disease, 
hence the suggestion that the change in sphingosine-
sphinganine ratios could be used as an early marker of 
fumonisins exposure in animals (Wang et al., 1992; Riley et 
al., 1993). 
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Normally, sphingosine inhibits protein kinase C (PKC), 
and thus modulates neoplastic transformation (Borek et al., 
1991). Protein kinase C plays a role in signal transduction 
and cell growth (Hansen et al., 1990), but its role in 
multistage carcinogenesis has not been firmly established 
(Weinstein, 1988). PKC has receptors for tumor promoters such 
as phorbol esters, and sphingosine had been shown to block the 
tumor promoting effects of phorbol esters by inhibiting the 
activity of PKC (Borek et al., 1991). Fumonisins block 
ceramide synthetase, an enzyme involved in converting 
sphinganine to ceramide (Wang et al., 1991). Sphingosine is a 
product of ceramide breakdown, therefore, fumonisins may 
increase sphinganine and decrease sphingosine. Because serum 
SO/SA ratios were altered in pigs exposed to fumonisins before 
the onset of disease (Riley et al., (1993), the alteration of 
this ratio might be critical in cancer induction by FB. 
Seemingly, the alteration of SO/SA ratios interfere with the 
ability to inhibit tumor promotion. The interference of these 
modulators by fumonisins might indicate a mechanism by which 
fumonisins induce cancer. Fumonisins cause atherosclerosis in 
vervets, and their atherogenic plagues contain sphingolipids. 
Since FB's also inhibit PKC, they may provide templates for 
therapeutic agents in cancer and atherosclerosis treatments 
(Norred, 1993) . 
Another mechanism by which fumonisins induce different 
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diseases in different animals has been speculated to be by 
their less polar derivatives, namely; the hydrolyzed 
fumonisins or aminopolyol derivatives (HFB or AP) (Abbas et 
al., 1993). Fumonisins are water-soluble, therefore the 
lipophilic aminopolyols might be more toxic. In vivo, the 
hydrolysis of fumonisins might occur through the action of 
carboxyl esterases found in many tissues and subcellular 
fractions. The esterases will hydrolyze the diester bonds to 
release the two tricarboxylic side chains. The somewhat 
lipophilic molecule formed could then be taken up more readily 
by membranes than the parent compound. Structurally, the 
hydrolyzed fumonisins are more similar to the sphingosine or 
sphinganine structures than are the fumonisins. Therefore, 
the aminopolyols might also alter sphingolipid metabolism in 
the liver. The synthetic analog of FB^ without the 
tricarboxylic side chains was as toxic as the parent analog in 
rhesus monkey renal cells, which suggests that HFB might be a 
toxic metabolite of fumonisins (Kraus et al., 1992). 
Increased toxicity of HFB has also been noticed in jimsonweed 
leaves and mammalian cell lines. Hydrolyzed FB^ and FBg were 
cytotoxic to mammalian cell lines and more phytotoxic to 
jimsonweed leaves than the parent compounds (Abbas et al., 
1993). A food survey on corn based products (Hopmans and 
Murphy, 1993) reported the presence of hydrolyzed FB^ (HFB or 
AP) in masa, a corn based product that is treated with lime 
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(Sydenham et al., 1991). The presence of HFB in masa could be 
of human health concern since lime-treated F, proliferatum 
infected corn containing 10 ppm HFB^ seemed to be at least as 
toxic as F. proliferatum-intected corn containing 50 ppm FB^, 
with respect to cholesterol and glutamate pyruvate 
transaminase and incidence of neoplasia (Hendrich et al., 
1993). A recent study on the comparative toxicity of 
fumonisins (B^, Bg and Bj) and N-acetyl derivatives of FB, and 
FB, (AF^ and AFg) as well as their respective aminopolyols (AP, 
and APg) indicate that the APs are toxic in cultured cells and 
not toxic in vivo. The AP or HFB showed greater cytotoxicity 
to rat hepatocytes (125 juM) than their parent compounds (FBs), 
while the N-acetyl derivativatives were the least toxic at 
1000 /xM. In contrast, weanling male Fischer rats that were 
fed 0.05 - 0.1% FB or the amonopolyols in diet for 21 days, 
followed by the 2-AAF/PH selection treatment 14 days after 
dietary exposure and 14 days before sacrifice lost more weight 
than the rats on aminopolyols (AP) diets and control diet 
(Gelderblom et al., 1993). The conflicting results concerning 
the toxicity of APs or HFB in vivo might be due to the fact 
that a corn culture material containing HFB was fed to rats 
(Hendrich et al., 1992) compared to feeding a purified toxin 
(Gelderblom et al., 1993), which suggest that there might be 
other unidentified components in the nixtamilized corn culture 
material responsible for the observed toxicity. 
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Carcinogenesis 
Carcinogenesis is a multistage process involving 
initiation, promotion of initiated cells and progression to 
tumor formation. Several models have been developed in an 
attempt to study the different stages of tumorigenesis. The 
earliest models involved mouse skin tumorigenesis (Boutwell, 
1974) . Rat liver is also useful because it is highly perfused 
by chemicals and hepatocarcinogenesis is readily quantified by 
numerous histochemical assays of preneoplastic markers coupled 
with computerized stereology. Tumors induced by carcinogenic 
agents can either be genotoxic or epigenetic. Genotoxic 
compounds are mutagens and alter the DNA directly or may 
require metabolic activation to form electrophiles which will 
form DNA adducts. Therefore, genotoxic agents have initiating 
activity. In contrast, epigenetic carcinogens are non-
mutagens and thus do not alter DNA directly. Their mechanisms 
as carcinogens are still incompletely understood. Carcinogens 
may also effect different stages of carcinogenesis, thus they 
maybe termed incomplete or complete carcinogens. Incomplete 
carcinogens are often initiators, while complete carcinogens 
have initiating, promoting (Miller and Miller, 1981) and 
progressing properties (Pitot et al., 1988a). There is also a 
dose-response for most carcinogens, which decreases with 
higher doses because of cell death (Iversen, 1988). 
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Although cancer development is a multistage process, it 
is not a continuous process involving a series of changes in a 
cohort of cells; rather, it is a discontinuous process 
involving the selection of "rare events" that occur in the 
cell. Normally, the initiated cells are repaired, but a "rare 
event" may prevent this natural repair process, resulting in 
altered cells. Another "rare event" occurs when a promoting 
agent is present, this event will selectively stimulate the 
growth of these altered cells. The next "rare event" 
stimulates the autonomous growth of this population of altered 
cells to form neoplasia. Since these processes depend on the 
occurrence of the "rare events", this might be the reason why 
cancer development tends to be a slow process (Farber, 1980). 
Sometimes the focal areas may develop within existing foci 
producing "nodules within nodules" or foci-within foci 
(Farber, 1973) however, this is an uncommon occurrence (Pitot 
et al., 1978). 
Histopathological analysis of stages of cancer indicate 
that during initiation, lesions smaller than the liver lobule 
develop. These are altered foci which appear within one week 
of exposure to a carcinogen. These altered foci do not 
compress the adjacent liver tissue, although they are clearly 
demarcated and different biochemically from the normal tissue. 
The persistent altered foci develop into neoplastic nodules 
which are generally larger than the area of several nodules. 
20 
and elevated from the rest of the surrounding hepatocytes. 
These nodules lose some of the characteristic altered enzyme 
activities of the foci. The nodules progress to carcinomas 
that are benign (if genotypic alteration did not occur) or 
malignant (if genotypic alteration occurred). The benign 
lesions are called adenomas, while the cancerous ones are 
called hepatocellular carcinomas (Williams, 1980). 
Initiation 
Initiation, the first stage of carcinogenesis, is induced 
by any chemical that alters the genetic structure of the DNA 
and it is irreversible. The initiation stage can also occur 
spontaneously in dividing cells (Ward, 1983). Initiation can 
be induced by a necrogenic dose of a carcinogen (e.g., >30 
mg/kg DEN). A single non-necrogenic dose of an initiator must 
be followed by a cell proliferator (e. g., CCl^) or partial 
hepatectomy before the damaged cells undergo DNA repair. If a 
carcinogen is given after a cell proliferator or PH, then 
initiation induction fails (Scherer and Emmelot, 1975). The 
number of focal lesions or enzyme-altered hepatic foci are 
used to quantify this stage (Pitot et al., 1988a). Initially, 
these islands of altered hepatocytes grow at the same pace as 
the unaltered hepatocytes, during promotion they are selected 
to proliferate faster. Quantitation of these altered foci is 
by biochemical markers which either indicate the loss of or 
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the increased activity of enzymes or cell components in the 
altered cells (Farber, 1980). 
The stability and heterogeneity of these markers has been 
reported by several scholars. For example, Pitot and 
associates (1978) demonstrated the phenotypic heterogeneity of 
enzyme-altered hepatic foci (AHF) in rats treated with 
diethylnitrosamine at 10 mg/kg after 24 hour partial 
hepatectomy, followed by a diet containing 0.5% phénobarbital 
(PB) eight weeks after DEN initiation. Rats which received 
this treatment had twice the relative proportion of foci 
exhibiting glucose-6-phosphatase (G-6-P), canalicular ATPase 
(ATPase) and gamma glutamyl transferase (GGT) compared to the 
controls, indicating the heterogeneity of the markers. 
The stability of enzyme-AHF markers has been demonstrated 
in several laboratories (Goldsworthy and Pitot, 1985; Farber, 
1980). Rats were treated according to the Pitot et al., 
(1978) regimen described above, except that some rats were 
given PB-free diet for 6 months after 3 or 4 months of the 
treatment. Removal of PB for 6 months did not have a 
significant effect on the presence of all three markers (G-6-
P, ATPase, GGT) demonstrating the stability or persistence of 
the markers. GGT scored the vast majority of markers at all 
times (Goldsworthy and Pitot, 1985). Despite the fact that 
these markers are persistent, they can revert depending on the 
time of exposure to promotion agent after initiation. Xu et 
22 
al., (1990) using GGT, PGST, ATPase and G-6-Pase markers, 
demonstrated that rats exposed to a promoting agent within 1 
day to 2 months after initiation did not show any variability 
in the volume percentage of the number of AHF, but an 11 month 
delay between initiation and promotion resulted in 20% fewer 
AHF. Therefore, initiation induction depends on the dose and 
time of initiation. High doses of the carcinogen cause cell 
death, and non-necrogenic doses must be coupled with partial 
hepatectomy within 24 hours of exposure to avoid the natural 
repair process of the initiated (mutated) cells depending on 
the age of the rats. By taking advantage of the proliferative 
nature of cells in growing animals, initiation can be induced 
by a non-necrogenic dose without partial hepatectomy in female 
and male rats at a few days of age (Peraino et al., 1981). 
Placental glutathione S-transferase is also an accurate 
marker for different stages of carcinogenesis, because very 
small foci were detected 48 hr after a single dose of 
diethylnitrosamine (10 - 80 mg/kg body weight) in 6 weeks old 
male Fischer rats (Moore et al., 1987). 
Promotion 
Promotion, the second stage of carcinogenesis, is induced 
by any substance that alters the genetic expression of 
information within the cell to stimulate growth of initiated 
cells. Promotion is the stage where the initiated cells are 
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selected for preferential growth; i.e., the initiated cells 
are selected to grow under conditions where normal cell growth 
may actually be inhibited (Farber, 1980). This stage is 
partially reversible and requires continuous exposure to the 
promoting agent. Promoting agents are effective only if given 
after an initiator and not alone (Miller and Miller, 1981). 
Unlike initiators, promoting agents exhibit a no-effect level 
and a maximal dose response in that any dose of promoter has 
the same effect on the promotion of initiated cells (Pitot, 
1990; Pitot and Sirica, 1980). The promotion stage has been 
demonstrated by Pitot protocol where a single dose of DEN was 
given to rats 24 hour after partial hepatectomy (PH), and 2 
months later the rats were fed diets containing 0.5% PB for 6 
months. The number of AHF was increased 5 times in PB fed 
rats. Some rats developed hepatocellular carcinomas (Pitot et 
al., 1978). Using a similar protocol except feeding PB diet 1 
week after DEN, and withdrawing and re-administering PB at 
certain intervals, Hendrich and associates were able to 
demonstrate the reversible nature of the promotion stage 
(Hendrich et al., 1986). 
The mechanisms of promoters during carcinogenesis has 
been hypothesized as being through "differential inhibition, 
differential stimulation or differential recovery" of 
initiated cells. The differential inhibition involves rapid 
growth of initiated cells due to the promoter, while 
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differential stimulation is the selective growth stimulation 
of altered cells. The third mechanism could be due to the 
inability of the initiated cells to recover; thus, in the 
presence of a promoter, these cells revert to the 
proliferating stage resulting in papillomas as in skin 
tumorigenesis (Farber, 1980). 
Progression 
Progression, the ultimate stage of carcinogenesis, is 
irreversible, and characterized by benign and/or malignant 
tumors. Agents that induce progression act on promoted cells 
to advance the initiated cells to neoplastic cells (Bitot et 
al., 1988a). 
Models of hepatocarcinogenesis 
Induction of liver tumors in the rats has been used as a 
model of cancer research since 1932 (Yoshida, 1932). Numerous 
models have been developed to investigate the mechanisms of 
neoplastic induction in rat liver. These models are based on 
the identification and characterization of preneoplastic 
lesions, especially altered hepatic foci (AHF), which precede 
hepatic adenomas and carcinomas (Goldsworthy et al., 1986). 
Variability in these models may be influenced in part by diet 
(Glauert and Pitot, 1986), age, sex and strain of the animal 
(Xu et al., 1990). A review by Goldsworthy and associates 
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(1986) places the different models in categories based on 
whether they prove initiation and/or promotion. The end stage 
of the models is the presence of AHF or obviously neoplastic 
cells. 
Historically, the earliest demonstration of the different 
stages of carcinogenicity were conducted by Sasaki and Yoshida 
(1935). Long term exposure of rats to carcinogens resulted in 
death or tumors. Removal of the carcinogen at certain periods 
stopped the progression of tumor to cancer (Rabes et al., 
1972). Other models are now available for analyzing stages of 
rat liver carcinogenesis. All the models involve a brief 
exposure to the initiating carcinogen, either in very young 
animals in which the liver is proliferating (Peraino et al., 
1984), or in partially hepatectomized livers of adult rats 
(Scherer and Emmelot, 1975; Solt and Farber, 1976). In these 
models, promotion is stimulated by a brief or prolonged 
exposure to a chemical or an environment that selects the 
initiated cells. 
Enzyme-altered hepatic foci (AHF) 
Enzyme altered hepatic foci are of clonal origin and used 
as markers of preneoplasia. These markers represent either a 
decrease or increase in a cell component or enzyme activity of 
initiated cells which indicate metabolic dysfunctions during 
hepatocarcinogenesis (Bannash et al., 1989). Altered hepatic 
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foci have decreased xenobiotic metabolism reflecting molecular 
alterations in neoplastic cells (Roomi et al., 1985). Table 1 
shows some of the altered enzyme or cellular components 
reported in AHF. 
The use of histochemical and biochemical stains has made 
it easy for the differentiation and identification of AHF. 
Histochemical stains are used to identify altered foci 
according to their staining reaction to hematoxylin and eosin 
(H & E) stains, while immunohistochemical stains are used to 
identify the different altered enzymes. These foci stain 
differently from the surrounding normal tissue. Using H & E 
Table 1. A selected list of altered enzyme or cellular 
components found in altered hepatic foci 
Markers of loss of cell component 
or enzvme activity 
Markers of increased cell component 
or enzvme activity 
iron storage glycogen 
^-glucuronidase 7-glutamyl transferase 
serine dehydratase placental glutathione S-transferase' 
canalicular ATPase 
glucose-6-phosphatase 
(adapted from Emmelot and Scherer, 1980) 
= (Sato et al., 1984) 
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stains, the AHF may be basophilic, eosinophilic or clear. 
The latter foci consists of vacuolated cells and thus, do not 
take up the stains. The persistent altered foci become 
neoplastic nodules, which are generally larger than the area 
of several lobules of the liver, and elevated from the rest of 
the liver tissue. Nodules maintain most of the altered or 
cellular component or enzyme activities similar to the foci 
(e.g., iron accumulation deficiency), but some activities such 
as GGT are lost (Williams, 1980). This loss of enzyme 
activity accounts for the difference in quantifying liver 
lesions using histology (H & E stain) and immunohistochemical 
stains. 
Gamma-glutamyl transferase (GGT) has been used most 
frequently in hepatocarcinogenesis. GGT is normally present 
in trace amounts in adult and regenerating liver cells, but it 
is very high in fetal hepatocytes (Pitot and Sirica, 1980). 
GGT is a membrane bound enzyme found in the secretory and 
absorptive tissues. It is mainly concentrated in the kidneys, 
the pancreas, and seminal vesicles, with trace amounts found 
in other tissues. GGT hydrolyses glutathione by cleaving the 
gamma-glutamyl group releasing glutamate (Hendrich and Pitot, 
1987). Abnormally high levels of GGT are found in liver 
tumors in mice and human hepatocellular carcinomas (Gerber and 
Thung, 1980). The leaking of GGT from hepatic cells during 
liver damage can be detected in serum at an early stage of 
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carcinogenesis (Sawaba et al., 1983). Induction of liver GGT 
during hepatocarcinogenesis might be a protective mechanism of 
the cells in an attempt to preserve their glutathione (GSH) by 
utilizing extracellular (GSH) (Hendrich and Pitot, 1987). 
Another AHF marker that has gained recognition is the 
placental glutathione-S-transferase (PGST). It belongs to a 
family of GST enzymes involved in the hepatic detoxification 
process. The GSTs exit as several isoenzyme viz., GST-A, GST-
B, GST-C and several subsections (Kitahara et al., 1983). 
Like GGT, the role of GST during hepatocarcinogenesis is to 
utilize the glutathione in an attempt to protect the AHF; 
thus, a combination of GST and GGT presence may enhance 
proliferation of preneoplastic cell (Hendrich and Pitot, 
1987). 
The scoring of AHF by PGST and GGT markers seem to 
decrease with age, but PGST is more persistent and scores a 
greater number of AHF compared to GGT, i.e., GGT scored 5 -10% 
less AHF, and 37% of the AHF were GGT negative (Tatematsu et 
al., 1988). Antioxidants such as BHA and BHT inhibit the 
growth of GGT -(+) AHF that have been initiated by DEN, and 
BHA inhibits the growth of PGST-(+) foci (Tatematsu et al., 
1988). Placental glutathione S-transferase is also an early 
marker of hepatocarcinogenesis. Single PGST-(+) foci appeared 
in rats that had been partially hepatectomized within 4 hour 
of initiation with DEN (80 mg/kg bodyweight). The rats that 
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were kept for 12 weeks still demonstrated large number of 
single PGST foci. The uninitiated rats without PH also had 
small PGST-(+) foci. Their results indicate that PGST is an 
early markers of neoplasia, it is persistent and could be used 
as markers of putative "initiated" cells (Moore et al., 1987). 
However, the use of PGST as a marker of spontaneous foci seems 
to be male specific. Mitaka and Tsukada (1987) demonstrated 
that in 18 and 23 month old rats, PGST scored 90% of the 
putative AHF whereas GGT-scored 75% of AHF in males, and in 
females both markers scored 20% of the AHF. While these 
results indicate the efficiency of PGST as a marker of 
putative preneoplasia, PGST markers might be useful more in 
male rats only. 
Quantitation of enzyme-altered foci (EAF) 
The quantitation of EAF for the characterization of the 
effects of putative initiating and promoting agents has been 
developed in explaining the models of hepatocarcinogenesis 
(Pitot and Sirica, 1980). Quantitation of EAF by computerized 
stereology is based on the mathematical principles of particle 
enumeration in solid mass. Stereological quantitation is 
applied to quantify discrete lesions in solid tissues. The 
methods transform the two dimensional analysis of EAF 
(Foci/cm^) to a three dimensional analysis - number of 
foci/cm^; number of foci/liver, the volume percentage occupied 
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by foci, and the mean volume occupied by foci (Campbell et 
al., 1982). Transformation of the number of foci per area 
into three dimensional data allow direct inferences about the 
effect of the carcinogen on the number and size of the foci. 
Analysis of AHF by stereological quantitation is based on the 
assumptions that foci are spherical, foci centers are located 
randomly within the sphere, and their size and location is 
independent of other foci. The main limitation of this method 
is that the three-dimensional estimation of foci with very 
small diameters cannot be computed (Morris, 1989). 
The use of stereological quantitation of EAF provides 
information on the analysis of the effect of different 
promoters during hepatocarcinogenesis. A comparative study on 
the mechanism of PB and a peroxisome proliferator (WY-14,643) 
showed that PB increased the number of AHF while WY-14,643 
increased the size of the AHF. This difference in the number 
of AHF demonstrated that the mechanisms of the two promoters 
are different (Popp and Goldsworthy, 1989). Schulte-Hermann 
et al. (1989) used radiolabelled %-thymidine to demonstrate 
that the increase in number of AHF during promotion is due to 
enhanced phenotypic expression of the foci and not due to 
formation of new foci with altered enzyme. This induced 
expression resulted in a larger volume occupied by the foci. 
The quantification of GGT-(+) AHF after withdrawal of PB in 
the Pitot protocol (1978) demonstrates the irreversibility of 
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initiated cells. The reversible nature of promotion is 
demonstrated by quantifying the volume AHF when PB was 
administered and then withdrawn, and readministered (Hendrich 
et al., 1986). Computerized stereological analysis can also 
be used to quantify multiple marker operations, thus enabling 
one to establish if a carcinogen induces multiple AHF 
(Hendrich and Pitot, 1987). 
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PAPER 1. FUSARIUM PROLIFERATUM-FEmiEmED CORN STIMULATES 
DEVELOPMENT OF PLACENTAL GLUTATHIONE S-TRANSFERASE-
POSITIVE ALTERED HEPATIC FOCI IN FEMALE RATS 
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Fusarium proliferatum-fermenteà. corn stimulates development of 
placental glutathione S-transferase-positive altered hepatic 
foci in female rats 
By 
S. Lebepe-Mazur^, T. Wilson^ and S. Hendrich^*. 
^ Department of Food Science & Human Nutrition, Iowa State 
University, Ames, lA. 50011. 
^ National Veterinary Services, USDA-APHIS, Ames, lA. 50010. 
*To whom correspondence should be addressed. 
34 
ABSTRACT 
Groups of eight six-week old female Sprague-Dawley rats 
were initiated with diethylnitrosamine (DEN, 3 0 mg/kg). 
Control and initiated groups were fed a semipurified diet, or 
diets supplemented with Fusarium prollferatura-contaminated 
corn to contain 20 or 50 mg/kg fumonisin B, (FB^). 
Histochemical staining for gamma-glutamyltransferase (GOT) and 
immunochemical staining for placental glutathione S-
transferase (PGST), markers of altered hepatic foci (AHF), 
were performed on serial frozen hepatic sections. Gamma-
glutamyltransf erase -(+) altered hepatic foci (AHF) were not 
found in any group. Treatment with DEN significantly 
increased the number of PGST(+) hepatocytes compared with the 
uninitiated groups (P<0.0004). Groups fed F. proliferatum-
containing diets also had a significantly increased number of 
PGST-(+) AHF compared with those fed no F. proliferatum 
(P<0.003). The volume percentage of liver occupied by PGST-
(+) foci was significantly greater in the groups treated with 
DEN (P<0.01) or F. proliferatum (P<0.03) compared with the 
controls. The mean focal volume occupied by AHF in the groups 
given DEN was also significantly greater than in the 
uninitiated groups (P<0.02). Fusarium proliferatum treatment 
also significantly increased mean focal volume (P<0.04). In 
conclusion, the feeding of F. proliferatum containing only 20 
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mg/kg FB^ promotes the development of DEN-initiated AHF in 
rats. Placental glutathione S-transferase is a more useful 
marker than GGT in detecting AHF produced by small amounts of 
F. proliferatum mycotoxins fed after a mild initiating 
treatment. 
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INTRODUCTION 
Fusarium proliferatum and F. moniliforme mycotoxins are 
natural contaminants of corn which may be found in human food 
and animal feed. The presence of F. moniliforme in corn is 
associated with human esophageal cancer in Southern Africa 
(1). Mycotoxins from this fungus, especially the fumonisins, 
are highly toxic to experimental animals, causing 
hepatocellular carcinomas (2) and cholangiocarcinomas in rats 
(3), equine leukoencephalomalacia (ELEM) (4, 5), and porcine 
pulmonary edema (PPE) (6). Fumonisin (FB^) is present in 
feeds associated with known cases of ELEM and PPE at 1-126 
/ig/g feed (7) . Fumonisin B^ is found in corn at approximately 
7.9 Mg/g in regions where human esophageal cancer is more 
prevalent (1). Corn products for human consumption commonly 
contain 0.2 - 2 jug/g FB^ (8). But, the cancer risk associated 
with a usual human intake of FB^ has not been established. 
Carcinogenesis is a prolonged process that produces a new 
population of cells with altered organizational, structural 
and biochemical properties. Altered expression or activity of 
enzymes such as gamma-glutamyl transferase (GGT), canalicular 
adenosine triphosphatase, glucose-6-phosphatase (9), and 
placental glutathione S-transferase (PGST) (10) is a 
biochemical marker of carcinogen-induced altered hepatic foci 
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(AHF). Placental glutathione S-transferase may be the most 
useful of these markers in quantifying hepatocarcinogenesis 
(10), because PGST appears quite early (11) and persists 
strongly throughout preneoplasia and neoplasia in human and 
animal tissues (12). 
The purpose of this study was to assess FB^ toxicity by 
exposing rats to F. proliferatum/corn culture material 
containing smaller amounts of FB, than have been previously 
studied, and to assess the utility of PGST as a marker of FB^-
promoted AHF. Studies feeding male rats either purified FB, 
(50 mg/kg) incorporated into the diet (2,13) or oven- or 
freeze-dried F. moniliforme/corn culture material containing 
approximately 40 mg/kg FB^ (4% corn culture) (14) have been 
conducted. Gamma-glutamyltransferase has been the only marker 
studied of FB,-promoted AHF (13). In this study, for six 
months, rats were fed 20 or 50 mg/kg FB^ supplied from crude 
F. proliferatum culture material, and preneoplasia was 
measured by computerized stereology (15). 
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MATERIALS AND METHODS 
All chemicals were purchased from Sigma Chemical Co. (St. 
Louis, MO), unless otherwise specified. Diet ingredients were 
obtained from Harlan Teklad (Madison, WI). 
Preparation of diets 
Lyophilized cultures of F. proliferatum strain M5991 
(obtained from Dr. Paul Nelson, Pennsylvania State University) 
were reconstituted in sterile phosphate-buffered saline, 1 ml 
of which was used as an inoculum for 300 g sterile aflatoxin-
free corn. The corn culture was incubated in the dark for 6 
weeks at 22-25° C. Corn culture was freeze-dried, assayed for 
FB^ content by P. F. Ross, National Veterinary Services Lab, 
Ames,lA (7), ground, and incorporated into basal diet in 
amounts of 3 - 10 g corn culture /kg diet to make diets 
containing 20 and 50 mg/kg FB^ (FB^^ and FBg^) . The basal diet 
was modified from the AIN-76 semipurified diet to contain 20% 
of kcals from fat (Table I, 16). 
Animals and treatments 
Forty-eight six-week-old female Sprague-Dawley (SD) rats 
were divided into 6 groups. Three groups were initiated with 
diethylnitrosamine (DEN, 30 mg/kg body weight) by oral 
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intubation in 0.1 ml dimethylsulfoxide (DMSO). One week 
later, rats were fed a diet containing 0, 20 or 50 mg/kg FB^ 
from F. proliferatum corn culture. Three other groups were 
fed diets containing 0, 20 or 50 mg/kg FB^ from corn culture, 
without initiation. These rats were initially dosed with 0.1 
ml DMSO each. The levels of FB^ incorporated into the diets 
were periodically confirmed by high pressure liquid 
chromatography performed by P. F. Ross, National Veterinary 
Services Laboratory, Ames, lA (7). Animals were caged 
individually and had a twelve hour light cycle. This type of 
housing and animal care was approved by the Iowa State 
University Committee on Animal Care. Semipurified diet (Table 
I) and water were available ad libitum. Body weights were 
recorded each month throughout the experiment. Rats were 
euthanized under a carbon dioxide atmosphere 6 months after 
DEN treatment. Slices from each of the three lobes of the 
liver were immediately frozen as a block on dry ice and then 
stored at -80° C for later immunohistochemical staining. 
Additional slices were fixed in phosphate-buffered formalin 
for histopathological evaluation. 
Immunohistochemical staining 
Two serial sections (10 /ixM thick) from each rat liver 
were stained for the presence of GGT- or PGST-positive AHF. 
Gamma-glutamyltransferase activity was determined (17). Liver 
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sections from DEN-initiated rats promoted with phénobarbital 
for 6 months (18) were used to verify the GGT staining. 
Immunohistochemical staining for PGST-(+) AHF was performed 
with a Vectastain ABC kit (Vector Laboratory, Burlingame. CA). 
Rabbit anti-rat POST serum had been prepared previously in our 
laboratory (19) . Computerized stereology was used to quantify 
the number of AHF, the volume percent of liver occupied by 
AHF, and the mean volume of AHF (15). Additional liver slices 
were processed by routine histopathological methods for 
hematoxylin-eosin staining (20) . Data were analyzed by 
analysis of variance using the Statistical Analysis System 
(SAS, Cary, NC) on the mainframe computer of Iowa State 
University. Data for numbers and percent volume of AHF were 
processed by the SAS Stem and leaf program before being 
analyzed by the PROC GLM analysis of variance program. The 
Stem and leaf procedures involved taking the cube root or 
fourth root of the numbers or percent volume PGST-(+) AHF 
respectively, thus normalizing the distribution of the data. 
For hematoxylin and eosin-stained hepatic sections, Fisher's 
exact test was used to determine differences from the control 
group. 
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RESULTS 
A few rats, randomly dispersed among treatments, were 
euthanized before the end of the experiment because of mammary 
tumor development and dental malocclusions which are common in 
this strain. Diet analyses for levels of fumonisins were 
consistent with the amounts that were supposedly incorporated 
into the diets. Whereas there was no statistical difference 
between groups with respect to body weight (Table II), the 
relative liver weight was significantly greater (P<.06) in the 
groups given DEN alone or given DEN and fed F. proliferatum to 
provide 20 mg/kg FB^ than in the control group. 
Gamma-glutamyltransferase-positive AHF were not noted in 
any group. The number of PGST-(+) hepatocytes was 
significantly greater in the rats treated with DEN than in the 
uninitiated groups (P<0.0004). Rats fed either dose of F. 
proliferatum had significantly greater numbers of PGST-(+) 
hepatocytes than did rats fed no F. proliferatum (P<0.003). 
F. proliferatum providing 50mg/kg FB^ produced more PGST-(+) 
hepatocytes than did the lower dose of F. proliferatum 
(P<0.09). There was no interaction between DEN and F. 
proliferatum (Table III). Altered hepatic foci in the groups 
treated with DEN and FB^ were very large with occasional 
single PGST-(+) hepatocytes (Figure 1). 
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The percentage of the volume of liver occupied by PGST-
(+) AHF was significantly greater in the DEN-initiated groups 
than in uninitiated groups (P<0.01). Rats fed DEN/F. 
proliferatum (FBjq) showed greater hepatic volume occupied by 
PGST-(+) AHF compared with the higher dose. The groups fed 
either dose of F. proliferatum had significantly greater 
hepatic volume occupied by PGST-(+) AHF than did the groups 
fed no fumonisin (P<0.03). There was a significant 
interaction between DEN and FB^ treatments (P<0.074), with a 
dose response in uninitiated rats but not in the initiated 
rats (Table III). 
Mean focal volume of PGST-(+) hepatocytes in DEN-
initiated groups was also significantly greater than in the 
uninitiated groups (P<0.02). The groups treated with DEN and 
fed F. proliferatum-corn culture material containing 20 mg FB^ 
/kg had significantly greater mean focal volume than the 
groups treated with DEN and fed F. proliferatum containing 50 
mg FB^ /kg (P<0.04) (Table III). 
Histopathology studies showed that all the groups treated 
with DEN had clear cell foci (CCF), with a significantly 
greater incidence of foci than in the control group (P<0.04, 
based on 2-tailed Fisher's exact test). The groups given DEN 
and F. proliferatum showed a dose response to F. proliferatum 
treatment, with the group fed F. proliferatum containing 50 
mg/kg FB^ having significantly more CCF than the control group 
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(P<0.002, Fisher's exact test). The uninitiated group fed the 
lower dose of F. proliferatum had no CCF, and the uninitiated 
group fed the higher dose of F. proliferatum (50 mg/kg FB^) 
had an incidence of CCF not significantly different from the 
control. DEN-initiated groups with or without F. proliferatum 
treatment also showed eosinophilic foci, subcapsular 
hemorrhage, and karyomegaly of the liver in conjunction with 
CCF. One rat from the group fed the lower dose of F. 
prolifératurn-fermented corn had bile duct proliferation (Table 
IV) . 
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DISCUSSION 
Cancer development is thought to be a multistage process 
involving initiation, production of heritable genetic 
alterations; promotion, expression of growth-promoting 
characteristics; and progression (21). Although FB, has not 
been shown to be genotoxic, Gelderblom et al. (2) reported 
complete hepatocarcinogenicity of 50 mg/kg purified FB^ fed to 
male rats for 18-26 months. Previous studies feeding FB,-
containing F. proliferatum corn cultures showed promoting 
effects in DEN-initiated rats (13). Our study tends to 
support the finding of Gelderblom et al. (2), in that AHF 
developed in uninitiated rats fed FB,, and suggests that as 
small an amount as 20 mg/kg FB^ may be tumor promoting, if not 
a complete hepatocarcinogen (Table III). Although our study 
was performed with FB^ supplied in F. proliferatum/corn 
culture material, fumonisins were probably the crucial 
components in initiating carcinogenesis. The fat-soluble 
fusarins, also likely components of F. proliferatum corn 
culture, have been shown not to be initiating agents when 
given to rats at 50 or 100 mg/kg before phénobarbital 
promotion (22) although they are mutagens (23). Cultures 
producing large amounts of fumonisins are likely to produce 
only small amounts of other F. proliferatum mycotoxins (l). 
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Other components in the corn culture material which remain to 
be identified may be partly responsible for the observed 
development of AHF. But, it is likely that FB, is primarily 
responsible for the development of AHF. 
The difference in relative persistence of markers of 
carcinogenesis might account for the absence of GGT from AHF 
in this study. GGT is unstable compared with PGST (12). 
Several studies have shown that GGT(+) AHF foci may disappear 
or are diminished over a period of time compared with PGST(+) 
foci (12,24,25,26). Greater stability of PGST-(+) hepatocytes 
than GGT-(+) hepatocytes during promotion is seen in data from 
hepatic sections of DEN-initiated, partially hepatectomized 
rats fed diets mixed with either 2-acetylaminofluorene, 
phénobarbital, or butylated hydroxyanisole which showed that 
37% of PGST-(+) foci were GGT-negative at 50 weeks after 
initiation (12). Perhaps GGT activity of AHF is only 
stimulated by more stringent carcinogenic regimens than used 
in the present study. A single dose of DEN was administered 
at six weeks of age, which is a very mild initiating stimulus 
in comparison with protocols such as the Solt-Farber (18), 
Pitot (27) or Peraino protocols (28) where GGT-(+) AHF are 
observed. These protocols initiate with DEN at a few days of 
age or after partial hepatectomy, and a very large dose of DEN 
(200 mg/kg) may be given (18). DEN at varying doses given at 
6 weeks of age in a protocol similar to the present study 
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produced PGST-(+) single cells and AHF, but no attempt was 
made to detect GGT-(+) AHF (11). 
Spontaneous development of PGST-(+) AHF was noted in some 
of the animals fed only basal diet (Table III). This is 
commonly age-associated (29,30,31). Placental glutathione S-
transferase, a persistent marker of hepatocarcinogenesis (12) 
seems to be more reliable than GGT in examining fumonisin 
carcinogenesis because even when small amounts of F. 
proliferatum mycotoxins (20 ppm FB^) were fed, PGST-(+) AHF 
could be detected (Table III). Therefore, PGST may be useful 
in quantifying F. proliferatum hepatocarcinogenesis. 
Lesions noted in the hematoxylin and eosin-stained 
hepatic sections do not correspond with the presence of PGST-
(+) AHF, although all the DEN-initiated rats showed clear cell 
foci (CCF), eosinophilic foci and other hepatocellular changes 
(Table IV). The relationship between the presence of PGST-(+) 
AHF and other hepatocellular changes is unclear. However, 90% 
or 20 % of eosinophilic foci in rats dosed with aflatoxin B, 
either phénobarbital (50 mg/kg diet) or nafenopin (100 mg/kg 
diet) respectively, expressed CCF, eosinophilic foci and GGT-
(+) AHF (32) . Mitaka and Tsukada (31) also reported the 
presence of GGT-(+) and PGST-(+) AHF adjacent to CCF. 
Hepatocellular alterations such as clear cell, eosinophilic 
and basophilic foci may progress to neoplastic nodules 
(33,34). The progression of PGST-(+) foci was not examined 
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(33). Increased PGST is a characteristic of single 
preneoplastic hepatocytes (11) which persists throughout the 
development of neoplasia, and is a marker of several forms of 
neoplasia (35). Therefore, the presence of PGST-(+) AHF in 
hepatic sections from uninitiated rats fed F. proliferatum 
corn cultures providing 20 mg FB^ /kg diet suggest that FB^ may 
be a complete carcinogen even at this low dose and exposure to 
corn naturally contaminated with Fusarium spp. containing as 
little as 20 ppm FB^ probably poses a cancer risk. 
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Table I: Basal Diet 
Ingredient q/kg 
corn oil 33 
beef tallow 56 
casein 199 
corn starch 409 
dextrose 199 
cellulose 50 
AIN-76 vitamin mix 10 
AIN-76 mineral mix 35 
CaCOj 4.5 
choline bitartrate 2.0 
dl-methionine 3.0 
ascorbic acid* 0.1 
As an antioxidant 
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Table II. Body weight and liver weight as percentage of body 
weight in rats dosed with DEN and Fusarium 
. proliferatum 
Treatment Body weight Relative liver weight 
CaJ 
Control (n=5) 315.2 ±15.4 3.0 ±0.47^ 
DEN (n=7) 317.0 ±31.1 3.4 ±0.26® 
FBjo (n=7) 304.1 ±24.5 3.1 ±0.25®'' 
DEN-FBjo (n=8) 295.8 ±31.5 3.3 ±0.21* 
FBgo (n=8) 294.5 ±26.4 3.2 ±0.28®'' 
DEN-FBgo (n=7) 296.4 ±25.0 3.2 ±0.25 ab 
N represents the number of rats in each treatment. All data 
are expressed as means ± standard deviations. Relative liver 
weight is the (liver weight/body weight) x 100%. Significant 
differences are noted by superscripts. Groups not sharing a 
letter are significantly different (p<0.06). 
Table III. Quantitative results of Placental glutathione S-transferase-positive 
altered hepatocyte foci [PGST-(+)-AHF] in rats dosed with DEN and 
Fusarium prollferatum corn culture material 
Treatment No. of PGST-( + ) AHF % Volume occupied by No. of PGST-f + ) AHF 
per liver PGST-(+) AHF per cm 
Control (n=5) 260+420 0.18+0.27 20±34 
DEN (n=7) 2120±1180' 0.57+0.11" 153+96' 
FBjo (n=7) 630+450'' 0.39+0.31*' 52±38 
DEN-FBjo ( n=8 ) 3670+3910 0.78+0.38= 282+302" 
FB50 (n=8) 1570+1640'' 0.63+0.24'' 134+152 
DEN-FBjo (n=7) 1460+1178 0.61+0.36 120±100 
N represents the number of rats in each treatment- All data are expressed as means + standard 
deviations. 
' The DEN-treated groups had significantly greater number of foci per liver (P<0.0004); percentage of 
liver occupied by PGST-(+) AHF (P<0.01); and mean focal volume (P<0.02) than the uninitiated 
groups. 
Groups treated with F. prollferatum culture to provide 20 or 50 FB,mg/kg had significantly greater 
number of foci/liver (P<0.003), and percentage of liver volume occupied by PGST-(+) AHF (P<0.03) 
than the groups fed no F. prollferatum corn culture. 
' The groups treated with DEN and F. prollferatum corn culture containing 20 mg FB,/kg had 
significantly greater percentage of liver occupied by PGST-(+) AHF (P<0.07) and PGST-(+) mean focal 
volume (P<0.04) than the groups treated with DEN and 50 mg FB,/kg. 
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Table IV. Results of microscopic examination of hematoxylin 
and eosin-stained hepatic sections from rats dosed 
with DEN and Fusarium proliferatum 
Treatment n NML CCF EF other 
Control 5 100% 0% 0% 0% 
DEN 7 14% 86%® 14% 0% 
O 
S 7 100% 0% 0% 14%* 
DEN-FBgo 8 62% 38%®'' 0% 12%" 
FBso 8 88% 12% 12% 0% 
DEN-FBgo 7 43% 57%*b 29% 14%"* 
Hepatic sections were paraffin-embedded, sectioned and 
stained with hematoxylin and eosin before microscopic 
examination. NML indicates that no microscopic lesions were 
observed in the hepatic sections. Some individuals had both 
CCF (clear cell foci) and EF (eosinophilic foci). Other 
hepatocellular changes noted were: * hemorrhage and bile duct 
proliferation; ** subcapsular hemorrhage; and *** karyomegaly of 
the liver. 
® These groups were significantly different from the 
control (p<0.004, Fisher's exact test). 
^ These groups were significantly different from the 
control (p<0.002, Fisher's exact test). 
Figure 1: Immunohistochemical stained liver sections showing 
placental glutathione S-transferase altered 
hepatocytes [PGST-(+) AHF] in (A) control, (B) 
diethylnitrosamine (30 mg/kg) initiated, (C) 
Fusarium proliferatum-fermented corn cultures 
containing 20 ppm FB^ and (D) DEN-initiated and fed 
Fusarium proliferatum-fermented corn cultures 
containing 20 ppm FB,. 
B 
1 
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PAPER 2. FUMONISIN B, IS FETOTOXIC TO RATS 
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Fumonisin B., is fetotoxic to rats 
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ABSTRACT 
Groups of 5-6 pregnant F344/N rats were dosed by oral 
intubation from days 9-13 of gestation with 30 or 60 mg 
purified fumonisin B, (FB^)/kg body weight, or with a fat-
soluble extract of Fusarium moniliforme/corn culture derived 
from an amount of corn culture that would provide 
approximately 60 mg/kg FB^. Control rats were dosed with 
water or corn oil. Food intake was monitored daily during 
dosing. Fetal bone development was examined after staining 
with alizarin red, whereas internal organ development was 
examined in hematoxylin and eosin-stained tissue sections. 
Although group differences in maternal body weight were not 
statistically significant, weight was 10% less in dams dosed 
with 60 mg/kg FB^ compared with the control group (p<0.119). 
Relative litter weight was significantly suppressed by 60 
mg/kg FB^ (p<ANOVA, 0.003). Ossification of the sternebrae 
and vertebral bodies was significantly impaired by FB, 
treatment (Chi-square test, p<0.01). Litters from mothers 
treated with a fat-soluble extract of F. moniliforme/corn 
culture did not show suppression of litter weight or 
impairment of bone development. Therefore, fumonisin B^ is 
fetotoxic to rats, suppressing growth and fetal bone 
development. 
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INTRODUCTION 
Mycotoxins are natural environmental contaminants that 
have been implicated as teratogens in animals (Hayes, 1981). 
Fumonisins, mycotoxins produced by Fusarium moniliforme are 
novel water-soluble carcinogens (Gelderblom et al., 1991). F. 
moniliforme contamination of corn is associated with human 
esophageal cancer (Sydenham et al., 1990). Fumonisins are 
also hepatotoxic and hepatocarcinogenic to rats (Gelderblom et 
al., 1991), and they cause equine leucoencephalomalacia (Thiel 
et al., 1991). Other mycotoxins produced by this fungus are 
the fusarins, which are mutagenic in the Ames Salmonella 
typhimurium test (Bjeldanes and Thompson, 1979). The 
carcinogenicity and/or mutagenicity of compounds is positively 
correlated with their teratogenicity (Juchau, 1989). 
Therefore, carcinogens and/or mutagens are possible 
teratogens. The mechanisms of action of mycotoxins as 
teratogens have been categorized in three ways. Mycotoxins 
can interfere with hormonal biosynthesis; e.g., zearalenone 
which have estrogen-like activity in mammals, can damage 
parental gametes producing infertility or abnormal offspring 
if successful fertilization occurs. Mycotoxins may cause 
fetal malformations especially during organogenesis by 
interfering with nucleic acid and protein biosynthesis of the 
fetus. This would interrupt normal cell differentiation and 
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organogenesis resulting in malformations. Mycotoxins may 
affect the fetus indirectly by affecting vital maternal organs 
such as the liver, reducing nutrient transfer to the fetus or 
increasing toxin transfer (Hayes,1981). 
Tricothecenes and zearalenone (F-2 toxin), mycotoxins 
produced by other Fusarium species, have been shown to be 
teratogenic in several animal species including rats (Hayes, 
1981). But the teratogenic effects of F. moniliforme 
mycotoxins such as fusarins and fumonisins have not been 
reported. Thus, the purpose of this study was to determine 
possible teratogenic effects of F. moniliforme mycotoxins, 
especially the fumonisins. 
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METHODS 
Preparation of Fusarium moniliforme mycotoxins 
Sterile, aflatoxin-free feed corn analyzed by P.P. Ross 
(National Veterinary Services Lab, Ames, lA.; Ross et al. 
1991) was .inoculated with lyophilized cultures of F. 
moniliforme strain M5991 obtained from Dr. Paul Nelson 
(Pennsylvania State University), that had been reconstituted 
in phosphate buffered saline, pH 7.4. This corn culture was 
incubated in the dark for three weeks at room temperature (22° 
C). The corn culture was freeze-dried, ground and extracted 
with acetonitrile;water (1:1). The extract was partitioned 
with ethyl acetate after which the water-phase was loaded onto 
an Amberlite XAD-16 column (Sigma Chemical Co., St Louis, MO). 
The column was washed with water and FB^ eluted with methanol. 
The eluate was dried under vacuum, redissolved in water and 
loaded onto a Lobar Cg-column (25x310 mm, Merck, Darmstadt, 
Germany). The column was washed with acetonitrile;0.1% 
trifluoroacetic acid (TFA)) in water (80:20), and FB^ was 
eluted with acetonitrile;0.1% TFA in water (50:50). The 
fraction was further purified using HPLC equipped with a semi-
preparative Cg^-column (Partisil 10 ODS-3; 9.4x250 mm, Whatman, 
Hillsboro, OR). The FB^ was eluted with 20% acetonitrile;0.1% 
TFA in water for 5 minutes, followed by a gradient from 20 to 
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70% acetonitrile every 5 minutes. The purity of the isolated 
FB^ was determined by analytical HPLC of the o-phthalaldehyde-
derivative and confirmed by GC-mass-spectrometry. The 
isolated FB, was approximately 80% pure. 
Five hundred grams of F. moniliforme/corn culture 
prepared as above was extracted with 1500 ml 
chloroform:isopropanol (1:1) solution overnight. The extract 
was concentrated to 30 mis by Buchi rotavapor (Fisher 
Scientific, Pittsburgh, PA) (Bjeldanes and Thomson, 1979). 
This was the fat-soluble extract. 
Dosing of rats 
The animals were housed individually in plastic cages and 
exposed to a 12 hr light and dark cycle. This housing was 
approved by the Iowa State University Committee on Animal 
Care. 
Supposedly timed pregnant F344/N rats (SASCO, Omaha NE) 
were divided into four groups, 9 rats in the experimental 
groups and 8 in the control group. The control group was 
subdivided into two equal groups which were dosed with water 
as a control for the water-soluble extract, and corn oil as a 
control for the fat-soluble extract respectively. One group 
was orally intubated with 60 mg/kg per day purified fumonisin 
B, (FB^Q) , a second group was given 30 mg/kg per day purified 
fumonisin B^ (FB^^) . The last group (FusX) was dosed with fat-
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soluble extract of F. moniliforme/corn culture material from 
an amount of corn culture which would provide 60 mg/kg FB., per 
rat/day (i. e. 12 mg/rat) . The F. moniliforme/corn culture 
contained 3700 ppm FB,, therefore 3 g corn culture/day would 
provide 12 mg FB^. The amount of fat-soluble extract egualed 
3/500 X 30 ml, or approximately 0.2 ml per rat/day, because 
500 g corn culture was extracted and condensed to a volume of 
30 ml. Diets and water were available ad libitum. 
The day when vaginal plugs were noticed after mating was 
designated day 1 of gestation according to the supplier. The 
dosing was carried out between days 9-13 of gestation which is 
within the critical period of organogenesis (days 6 to 15) 
(Wilson, 1973). During days 9-13, food intakes were recorded. 
Maternal body weights were recorded on arrival and on the day 
of necropsy. Throughout the study, rats were fed semipurified 
diets based on AIN 76 (Table 1) (National Research Council, 
1978). 
Maternal necropsy and fetal examination 
On day 20 of gestation the rats were euthanized under 
carbon dioxide atmosphere. The uterine horns were examined 
for resorption sites before the pups were removed. Litter 
weights and maternal carcass weights were recorded. Gross 
fetal malformations were examined before incising their 
abdomens above the umbilicus, approximately two-thirds of the 
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litter were placed in 95% alcohol. The remaining fetuses were 
placed in 10% formalin. The litters in alcohol solution were 
saved for skeletal analysis and the formalin-fixed fetuses 
were saved for crown-rump measurements and for histological 
screening of congenital malformations of internal organs 
(Persuad, 1985). 
Histological analysis 
From the formalin-fixed pups, three sections, each 3-4 mm 
thick from the thoracic, hepatic and urogenital regions were 
cut and embedded in paraffin (Palmer, 1978). These were 
further cut into 10 micrometer sections using a microtome. 
Four serial sections were mounted on slides and stained with 
hematoxylin-eosin stains by methods described by Sheehan and 
Hrapchak (1980). Harris' hematoxylin was used as a primary 
stain after the tissues had been hydrated. One percent HCl in 
70% ethanol was used as a differentiator and eosin as a 
counterstain. Histological analysis for organ development was 
done by examination of slides under a light microscope. 
Skeletal analysis 
Ethanol-fixed pups were stained by the modified Dawson 
technique for staining fetal skeletons (Lorke, 1977). 
Alizarin red S dye (0.8 g/100 ml of 0.7% potassium hydroxide) 
was used to stain the skeleton after the tissue and fat had 
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been dissolved in 0.7 % potassium hydroxide solution for 1 
week. The stained fetuses were then stored in glycerol for 
examination under a dissection microscope. Skeletal 
development was assessed for hypoplasia, under- or 
extraossification, misshapes, supernumeracy (for ribs) and 
branching of the vertebral arch (Persuad, 1985; Taylor, 1986). 
Analysis of data 
The Statistical Analysis System computer program (SAS, 
Cary, NC) for one way analysis of variance was used to analyze 
animal data, and the least significant differences between 
treatment means were determined by Duncan's multiple range 
tests. Differences between each treatment and the control 
group in the incidence of skeletal variations were calculated 
by Chi-square tests using the two-way contingency analysis 
(Denenberg, 1976). 
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RESULTS 
Data analysis was based on pregnant rats only because 
about three rats in each group were not pregnant, therefore 
data were combined for the controls dosed with oil or water. 
Maternal body weights on day of arrival and at sacrifice 
were not significantly different among groups (p<0.1189), 
although rats dosed with 60 mg/kg FB^ weighed 10% less 
compared with control dams. Diet intake during dosing was 
similar in all groups (Table 2). No resorption sites were 
noted in any group. 
Growth impairment in the fumonisin-treated rats was 
reflected in crown-rump lengths because the FB^g group differed 
significantly from the FusX group (p<0.001) (Table 2). 
Although litter sizes were the same, litter weights per number 
of pups in the fumonisin-treated groups was significantly 
reduced compared with the control (p<0.003) with a dose 
response to fumonisin treatment. Litters from the FusX-
treated dams did not show any sign of toxic effects (Table 2). 
Maternal and fetal weights were significantly correlated (r= 
0.56, p<0.005). 
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Histological examinations 
No microscopic sections showed congenital abnormalities. 
There were normal chondrocytes and osteoblasts in the 
vertebral and sternebrae portions of the hematoxylin and 
eosin-stained tissues suggesting delayed ossification, which 
was seen in the alizarin-stained fetuses of the FB^-treated 
dams. 
Skeletal examinations 
Fetotoxic effects of FB^ were noted in litters from the 
FB^-treated rats (Table 3). The most outstanding anomalies 
were the lack of ossification and absence of the sternebrae, 
which were found to a significantly greater extent in FB,-
treated groups compared with the control group (p<0.01). All 
groups showed incomplete ossification of the sternebrae where 
either the third and/or fourth sternebrae were not ossified. 
Underossification of the vertebral bodies was also present to 
a significantly greater extent than the control in the FB^Q 
litters (p<0.01) but not in the FB^g litters. Fumonisin B,-
tréated groups also had misshapen ribs, skull hypoplasia or 
unossified phalanges (Figure IB) although their incidence was 
not significantly greater than in the control group. 
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DISCUSSION 
The reduced body weights of dams indicate possible 
maternal toxicity which correlates with fetal body weights and 
skeletal defects (Khera, 1984). This positive correlation has 
been noted in mice using a variety of structurally unrelated 
compounds that produced toxic effects in the mothers (Ryan et 
al., 1991). Although maternal body weights were not monitored 
continuously, diet intakes were similar during dosing (Table 
2) , suggesting that any birth defects noted were not due to 
food restriction (Johnson, 1965; Anderson et al., 1980). 
Litter weight is the most sensitive and consistent 
measure of toxicity (Ryan et al., 1991) compared with other 
parameters such as fetal resorption and percent abnormal 
fetuses, which may occur spontaneously in some animals 
(Gaylor, 1978). Fetal growth suppression in the fumonisin-
treated rats may be due to impairment of fetal nutrition, 
placental function or altered fetal metabolism due to the 
toxin (Manson and Wise, 1991). But, probably the suppressed 
fetal weights are due to decreased maternal weights in the 
fumonisin-treated rats as suggested by a review of the 
teratogenicity of numerous chemicals (Khera, 1984). Because 
FB^ is hepatotoxic, it might have caused damage to the livers 
of the mothers thus interfering with nutrient transfer to the 
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fetuses (Hayes, 1981; Manson and Wise, 1991). F. moniliforme-
contaminated corn extracts inhibit protein synthesis in 
cultured hepatocytes (Norred et al., 1990), which suggest a 
mechanism of growth inhibition in vivo. Another possibility 
could be that the fetuses developed biochemical defects early 
in gestation due to FB, and thus were unable to use nutrients 
efficiently, producing low birth weights. FB, alters 
sphingosine metabolism (Wang et al., 1991), and sphingosine 
inhibits Ca^*-dependent Na*/K^ ATPase and protein kinase C 
(Oishi et al., 1990). Therefore, it is possible that FB, 
inhibition of sphingosine metabolism might have increased 
Na*/K* pump activity resulting in less energy deposition and a 
decrease in body weight. Until a definite stereochemistry and 
mode of action of fumonisins are clarified, only speculation 
is possible regarding the biochemical bases of the effects of 
fumonisin on fetal development. 
Normal ossification of the sternebrae is complete at 
birth except for the fifth and sixth sternebrae (Taylor, 
1986) , but in this study even some of the controls had one or 
two sternebrae not ossified. This might be due to spontaneous 
malformations which may occur in some strains of laboratory 
rats (Persuad, 1985; Szabo, 1989). Osteogenesis of the 
vertebral bodies occur from day 18 of gestation until after 
birth (Gaylor, 1978; strong, 1925) but in this study litters 
from the fumonisin-treated rats showed lack of ossification at 
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day 20 even in the lumbar and thoracic regions which are 
normally ossified by day 18 or 19 of gestation. The lack of 
ossification of sternebrae and vertebral bodies could be 
caused by general growth impairment due to FB^ or to FB,-
altered intracellular metabolism of calcium. Rat placenta 
contains calcium binding proteins (CaBP) immunologically 
similar to vitamin D-dependent CaBP found in the duodenal 
mucosa (Garel, 1987). The chemical structure of FB^, by 
virtue of its propane-l,2,3-tricarboxylic acid plus 2-
acetylamino side chain structure (Bezuidenhout et al., 1988), 
indicates a possible Ca-binding capacity of this mycotoxin. 
It is possible that FB^ interferes with placental CaBP, thus 
affecting Ca absorption by the fetuses. The mechanism of FB^-
impaired bone development deserves further study. 
Ossification defects induced by an unknown toxin from 
Fusarium roseum have been reported in female broiler chicks 
which have been exposed to either 2% F. roseum incorporated 
into the diet (Haynes et al., 1985), or 3 - 5 mg/ml aqueous 
solution (Haynes and Wasler, 1986) from day one to two weeks. 
Tibial dyschondroplasia was noted as early as day 4, and was 
severe at 2 weeks (Haynes and Wasler, 1986; Haynes et al., 
1985). Although this defect is common in chickens, an 
unidentified F. roseum mycotoxin exacerbated the defect. Due 
to effects on bone development, fumonisins might be related to 
this unidentified mycotoxin. The absence of fetal or embryo 
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toxicity in the fat-soluble extract might be due to the low 
levels of mutagenic fusarins (80 mg/kg culture material) in 
fumonisin-containing F. moniliforme (Sydenham et al., 1990). 
Although they are mutagenic, fusarins have been shown not to 
be carcinogens (Gelderblom et al., 1986), and therefore they 
may not cause embryotoxicity or teratogenicity. Although 
other unknown factors in the 80 % pure FB^ may have 
contributed to the observed suppression of fetal body weight 
and improved ossicification, these results suggest that FB^ is 
fetotoxic if not teratogenic to rats. A small dose of a fat-
soluble extract of F. moniliforme was not fetotoxic. However, 
more studies need to be conducted using fumonisins of greater 
purity and larger numbers of rats. The U.S. and Canada have 
established a standard (20 rats/group) to allow for 0.02-0.85% 
spontaneous congenital malformations that occur in rats 
(Persuad, 1985). But these numbers are to be used after 
initial studies. In this study, 8 to 9 rats/group were used 
as a recommended number for testing teratogenic potential of a 
new chemical (Manson and Wise, 1991). Furthermore, more 
studies are needed because fumonisins are commonly found in 
corn products in the human diets in amounts of 0.2 - 2 ppm 
(Sydenham et al., 1991). Therefore, fumonisins pose a 
potential human health risk during pregnancy. 
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Table 1: Basal Diet. 
Ingredient g/kg 
corn oil 33 
beef tallow 56 
casein 199 
corn starch 409 
dextrose 199 
cellulose 50 
AIN-76 vitamin mix 10 
AIN-76 mineral mix 35 
CaCOj 4.5 
choline bitartrate 2.0 
dl-methionine 3.0 
ascorbic acid* 0.1 
As an antioxidant 
Table 2. Animal data 
Treatment Dose of FB Initial body Final body Diet intake Mean litter Mean 
(mg/kg/rat) weight weight during dosing weight (g) length 
fat fa) fa) /no. of DUDS (cm) 
Control 0 155.3 218.0 86.3 1.9' 2.7* 
n=6 (16.3) (9.8) (3.6) (0.2) (0.1) 
FBjo 79-6 151.2 206.0 89.8 1.5" 2.6^ 
n=5 (4.6) (8.9) (7.6) (8.6) (0.2) (0.1) vo 
FB30 40.3 149.4 213.2 85.0 1.7' 2.5= 
n=6 (2.9) (11.5) (13.3) (19.7) (0.2) (0.1) 
FusX 158.6 221.7 91.5 2.0' 2.8* 
n=6 (4.6) (10.2) (5.3) fO.l) (0.1) 
All data are expressed as means + standard deviations (). N represents the number of rats in each 
treatment. Groups not sharing a letter are significantly different, p<0.05, one way ANOVA, with least 
significant differences determined by Duncan's multiple range test. 
Table 3. Percent incidence of skeletal anomalies in 20-day old fetal rats dosed with 
FB^ or FusX on days 9-13 of gestation 
1 or 2 sternum Sternum Hypoplasia of 
Treatments ossified hypoplasia vertebral bodies 
Control 41% 0% 0% 
n=22 
FB^O 28% 72%® 33%® 
n=18 
FBjo 19% 77%® 29%® 
n=31 
FusX 48% 4% 0% 
n=23 
N represents the number of pups in each treatment.® By a Chi-square test, two-
way contingency plan, these groups showed greater than expected frequencies of 
anomalies, p<0.01. 
Figure l: Skeletal development of (A) control and (B) fumonisin-treated pup. Panel 
A shows a pup from a control dam, with normally shaped ribs, and normal ossification 
of the phalanges and vertebral bodies. Panel B shows a pup taken from a dam treated 
with 60 mg/kg fumonisin B,. It shows under-ossification of the vertebral bodies of 
the cervical and lumbar regions as well the phalanges. 
< 
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PAPER 3. PRODUCTION OF FUMONISINS BY FUSARIUM PROLIFERATUM 
M5991, M6104 AND M6290 IN LIQUID CULTURE MEDIUM AND 
THE METABOLISM OF 14C-LABELLED FUMONISIN B, IN RATS. 
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Production of fumonisins by Fusarium proliferatum M5991, M6104 
and M6290 in liquid culture medium and the metabolism of 14C-
labelled fumonisin B, in rats. 
By 
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ABSTRACT 
Fumonisins are readily produced by various Fusaria 
cultures on corn, a solid substrate medium. The production of 
fumonisins in most basal liquid medium is either very low or 
requires a long incubation period. Liquid media used to 
produce fumonisins were used either singly or in various 
combinations to find the most suitable medium for fumonisin 
production. Fumonisin was produced by F. proliferatum 
lyophilized cultures grown in basal salt medium that was 
supplemented with thiamin, riboflavin, pantothenate, niacin, 
pyridoxamine, and thiotic acid (500 jLtg of each/L) , and folic 
acid, biotin and vitamin (50 nq of each/L) , and 25 mg 1-
methionine/100 mL medium. The cultures were incubated for 48 
h at 22 ± 2® C while shaking at 50 rpm, in a pre-enrichment 
medium containing a malt extract as the main carbohydrate 
source. A 50 mL aliquot of the culture was centrifuged and 20 
mL of the supernatant was inoculated into a 100 mL basal 
medium in Roux bottles (VMR Scientific, Philadelphia, PA). 
The amount of FB^ produced was 340 /xg/mL after 24 days 
incubation at 22±2° C and 50 rpm. Supplementing the basal 
salt medium with methionine increased the production of FB^ by 
10 folds compared to medium without methionine after 16 days 
of incubation, therefore methionine supplemetation is 
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important for FB^ production. The metabolism of ^C-labelled 
fumonisin B^ showed that a single dose (0.1 ^ Ci) of FB was 
excreted almost entirely within 24 hours. The amount of ^ 'Re­
labelled FB^ recovered in feces was 96%, 2.5% in urine, 0.7% 
in liver and kidneys. There was no quenching in the blood. 
Only 4% of the counts were not accounted for. This implies 
that very small amounts of FB^ are required to cause disease. 
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INTRODUCTION 
Fusarium moniliforme, a fungus found contaminating 
various grains, especially corn, implicated in outbreaks of 
leukoencephalomalacia in horses (Marasas et al., 1988), 
hepatocarcinogenicity and hepatotoxicity in rats (Gelderblom 
et al., 1991), pulmonary edema in pigs (Osweiler et al., 
1992) ; has been successfully grown in solid substrate medium 
but not liquid medium. High levels of fumonisins B1 (FB,) 
(6.4 g/kg of corn) (Nelson et al., 1991) and >7 g FB^/kg 
(Nelson et al., 1992) have been produced on corn medium using 
F. moniliforme and F. nyagamai cultures, respectively. 
Purification of fumonisins from the solid (corn) medium is 
very cumbersome and expensive due to co-extraction of numerous 
interfering compounds (Gelderblom et al., 1988; Vesonder et 
al., 1990), hence the need to develop a liquid medium that 
will support the production of fumonisins. Production of 
tricothecenes (T-2), mycotoxins produced by Fusarium 
tricinctum, has been successful in yeast extract sucrose (YES) 
liquid medium. Levels close to 1000 ppm T-2 were produced 
after 6 weeks of incubation which declined to 50 ppm at 7 
weeks (Gabal et al., 1983). Fungi producing trichothecenes 
are commonly found in corn, cattle feed and mixed feed (CAST, 
1989) similar to fumonisin producing fungi. 
Successful production of FB, (74 mg/L) on a basal liquid 
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medium supplemented with glucose and ammonium sulfate and 
maintained at pH 5.0 has been reported by Jackson and Bennett 
(1990). Plattner and Schackelford (1992) were able to produce 
FB^ at levels ranging from 20 - 53 /xg/mL in liquid culture 
used for growing Alternaria alternats, a tomato fungus that 
produces a mycotoxin structurally similar to FB^. The medium 
used contained potato dextrose broth and 0.1% yeast (Gilchrist 
and Grogan, 1976). When this medium was supplemented with 25 
mg methionine/100 mL of medium, 53 nq/mL FB., was produced 
after 13 days of incubation at 25° C, and only 30 jug/mL was 
produced after 21 days of incubation when 100 mg methionine. 
So far, the highest level of FB^ produced from a liquid 
culture is 140 ppm when A. alternata culture were used (Chen 
et al., 1992). This method however, requires a long 
incubation period (110 days) to produce this amount. Aeration 
of the growth medium during incubation seem not to play an 
important role in FB^ production as suggested by Jackson and 
Bennett (1990). Plattner and Schackelford (1991), Gabal et 
al., (1983), and Chen et al. (1992), incubated their liquid 
cultures without aeration (stationary). During storage, 
production of fumonisins from Fusaria-contaminated corn 
require temperate moist conditions (Romer and Maune, 1993). 
These conditions have been simulated in the laboratory using 
mycotoxin-free cracked corn kernels that had been autoclaved 
twice before inoculation with lyophilized cultures of F. 
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moniliforme or F. proiliferatum. Suitable incubation 
temperature was found to vary from 20 -25° C, with maximum FB, 
(17.9 g/kg) produced by corn cultures incubated at 20° C for 
13 weeks (Alberts et al., 1990). 
The metabolism and ultimate fate of FB^ is not yet well 
characterized. Fumonisins seem to be entirely excreted in 
feces when the exposure route is oral and 66% in feces when 
the route of exposure is through intraperitoneal injection 
(Shephard et al., 1992a). 
The aim of this experiment was to develop a liquid medium 
that would produce sufficient levels of fumonisins within a 
reasonable period that could be radiolabelled, and 
furthermore, to determine the disposition of labeled fumonisin 
B1 after a single dose. 
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MATERIALS AND METHODS 
Materials: Malt extract broth was obtained from BBL 
(Cockeysville, MD). Potato dextrose broth, yeast extract, and 
peptone were obtained from Difco Lab (Detroit, MI). 
ScintiVerse^" Bio-HP scintillation analyzer, (NH^)2^0^, 
CaClg.ZHgO, FeSO^.VHgO, KH^POA, NaCl, MnSO^.H^O, MgSO^.THjO, 
(NH^)Cl and NH^HgPO^ were obtained from Fisher Scientific 
Chemical Co. (Springfield, NJ). Glucose, thiamin, riboflavin, 
pantothenate, niacin, pyridoxamine, thiotic acid, folic acid, 
biotin and vitamin B12 were obtained from Sigma Chemical Co. 
(St. Louis, MO). 1-Methionine was obtained from Gibco Lab. 
(Grand Island, NY). Fusarium proliferatum strains M5991, 
M6104 and M6290 were obtained from Dr. Paul Nelson 
(Pennsylvania State University). 
Experiment l 
Fusarium proliferatum cultures were reconstituted in 5 ml 
sterile phosphate buffer and inoculated into a 500 ml sterile 
pre-enrichment medium (Table II) in an culture flask. The 
medium was incubated at room temperature (25 °C ± 2 °C) for 48 
hours while shaking at 5 rpm. An aliquot of the pre-
enrichment medium was transferred to a previously autoclaved 
growth medium (Table II) which was supplemented with 500 ^ g/L 
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each of thiamin, riboflavin, pantothenate, niacin, 
pyridoxamine, and thiotic acid, and 50 nq/h each of folic 
acid, biotin and vitamin B12 (Jackson and Bennett, 1990; Table 
I) to make a 1:10 dilution (250 mL total). The cultures were 
grown in 2 L culture flasks. Incubation was at room 
temperature (22 - 27 °C) for 24 days on a shaker (50 rpm). 
Approximately 5 ml of the culture medium was sampled every 
other day to determine FB production over time. It was 
assayed by thin layer chromatography, and confirmation of FB 
was made by high performance liquid chromatography (Ross et 
al., 1992). An aliquot was taken each day to determine the pH 
of some cultures, whereas in other batches the pH was not 
adjusted. The pH was adjusted to 5.0 with either HCl or NaOH. 
Several attempts were made to produce FB^ in liquid culture 
using the methods employed by Jackson and Bennet (1990) (Table 
1) in order to compare FB production of the two media. 
Production of FBg and FB^ by F. proliferatum strains M6104 
and M6290 respectively were cultured similarly, except that pH 
was not adjusted. 
Experiment 2 
Table II medium was used but pH was not adjusted. On day 
8 of incubation, which was established as the day when FB 
production began, 100 juCi L-[methyl -labeled methionine 
(with specific activity of 2.0 GBq/mmol or 55.0 mCi/mmol) 
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(DuPont, Wilmington, DE) was added to the 250 raL of growth 
medium and incubated for 4 days. Fumonisin was extracted 
from the medium by methods of Cawood et al. (1991). At the 
end of 12 days of incubation, the liquid culture produced 3.8 
fiCi ± 1.4 of ^ C-labeled FB, (specific activity of 
0.14GBq/mmol) . The FB, was 85% pure, therefore, the total 
amount of ^^C-labeled fumonisin was 33.5 mg. The material was 
diluted in 3.8 mL distilled water to give a ^ ^C-FB, 
concentration of 1 /iCi/mL. Four rats with an average weight 
of 114 g were placed in metabolic cages and had free access to 
food and water. Three rats were gavaged with 0.1 juCi ^'^C-FB, 
(0.1 ml). The fourth rat was dosed with water to be used for 
calculating the amount of quenching. After 24 hours rats were 
killed by COg anesthesia and immediately decapitated to 
collect blood. Liver, kidneys, and thigh muscle, and all 
urine and feces were collected. Approximately 1 g of liver, 
muscle or feces, or 0.3 g of kidney, or 1 mL blood or urine 
were placed in 10 mL scintillation fluid. Radioactivity was 
counted on Beckman LS3801 counter (Beckman Instruments Inc., 
Irvine,CA) within 24 hr after sacrifice. 
F. proliferatum M6104 and M6290 cultures were grown using 
the same procedures as for producing FB^, but were not 
labelled with ^C-methionine. These cultures were incubated for 
40 days. Other F. proliferatum M5991 cultures were also 
incubated for 40 days. 
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Experiment 3 
Glucose in the pre-enrichment medium was substituted with 
a malt extract because it has been reported that production of 
fumonisins in cultures require a simple carbohydrate medium 
(Nelson, 1992). The culture flasks were substituted with flat 
Roux bottles (VMR Scientific Co, Philadelphia, PA) to increase 
the surface area and allow more air circulation. On a 
subsequent trial, 25 mg 1-methionine/lOO mL medium (Table II) 
and vitamins were added to the medium. Production of FB in 
this medium was compared to the medium used by Plattner and 
Schakelford (Table III). The medium used by Plattner and 
Schakelford was supplemented with vitamins (Table I) in one 
flask. 
Production of FB2 and FB3 from F. proliferatum (M6104 and 
M6290) was attempted using similar procedures except that 
Gilchrist and Grogan medium was not supplemented with 
vitamins. 
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RESULTS AND DISCUSSION 
Production of FB, 
Fusarium proliferatum M5991 culture grown on Jackson and 
Bennetts' (1990) medium produced <100 ppb FB, at all times, 
whereas, the medium in Table II supplemented with vitamins 
produced more fumonisin (10 ppm) after 24 days of incubation 
compared to 6 ppm when pH was adjusted (Table IV). But when 
methionine, [L-methyl -labelling was incorporated into 
medium (described in Table II, without pH adjustment) in the 
second experiment, 33.5 ppm ^ ^-labelled FB^ was produced after 
14 days incubation. Attempts made to reproduce or improve the 
amounts of FB^ production using the second medium (Table II) 
failed initially. Less than <100 ppb FB, was produced each 
time. The failure to reproduce our results might have been 
due to temperature variability (20 - 35 °C), which was 
uncontrollable during this time. The cultures seemed to 
undergo alcoholic fermentation within 3 days when temperatures 
were >27 °C. Another reason could be that F. proliferatum was 
used instead of F. moniliforme. FB^ is the main metabolite of 
F. moniliforme, and it is produced to a lesser extent by F. 
proliferatum (Ross et al., 1990). The ^ C-labelled cultures 
used for metabolism studies produced 33.5 mg FB^/L. 
Methionine is probably required in the biosynthesis of FB^ 
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(Plattner and Shackelford, 1992). F. proliferatum M5991 
culture that were incubated for 40 days produced 5 ppm FB,, 
and the FB, production increased over time (Figure 1). 
Substituting a malt extract for glucose in the third 
e x periment and using flat culture bottles produced 5-10 ppm 
FB, after 21 days of incubation at room temperature (Table 
IV). The initial pH was 6.1 and remained at 3 from day 4 of 
incubation. Adding 25 mg methionine to the medium increased 
the production of FB, extensively (230 jug/mL) compared to 22.2 
Hg/mL in medium without methionine after 16 days of 
incubation. The addition of vitamins to the medium used by 
Plattner and Schakelford stimulated FB, production such that 
within 10 days of incubation, 68.2 fig FB,/mL was produced 
compared to 51.7 jug FB,/mL of medium without vitamins (Table 
V). Using this medium, Plattner and Shackelford (1992) 
obtained 53.0 jug FB,/mL within 13 days. 
Attempts to produce FB^ and FB^ within 14 days of 
incubation were not successful (<100 ppb) was produced, thus 
the cultures were incubated for 40 days. Production of FBg or 
FBj by F. proliferatum (M6104 or 6290, respectively) ranged 
from 0.05 - 0.2 ppm FBj or 0.1 - 0.5 ppm FBj, with optimum 
production at various time points (Figures 2 & 3). These 
strains also supported production of FB, at earlier stages of 
incubation, and once the FB, production declined, then FBg or 
FBj production occurred. These results show that FBj and FB^ 
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require longer incubation, and suggest that FBg and FB3 may be 
derived from FB,, or that FB^ inhibits FBg or FBj production 
i.e., FB, production must be shut off before FBg or FB3 are 
produced. Results from the third experiment however, indicate 
that the availability of suitable substrates for the fungi 
induce FBg and FB^ production at an earlier stage of 
incubation. F. proliferatum M6104 produced 64.3 jug/mL FBg 
within 11 days of incubation when Table II medium was used 
(with malt extract), and 84.3 jitg/mL FBg was produced after 11 
days of incubation when 25 mg 1-methionine was added to 100 mL 
of the medium. The Gilchirst and Grogan medium produced 43.8 
jug/mL FBg after 11 days of incubation. Production of FBj from 
F. proliferatum M6290 was 7 /itg/mL in Table II medium without 
methionine and only 4.6 /iig/mL was produced in the methionine 
supplemented medium within 11 days of incubation. Production 
of FB^ by these strains ranged from 0.03 - 0.84 /ig/mL in all 
the media and did not seem to inhibit production of FBg or FB3 
unlike the earlier experiments (Figures 1 & 2). The use of 
basal salt medium supplemented with 1-methionine seem to 
support independent production of FBg and FB3 from 
F.proliferatum. There was a 430 and 23 fold increase in the 
production of FBg and FBj from F. proliferatum grown in 
methionine and vitamin supplemented medium, previously pre-
enriched in medium containing malt extract compared to the 
unsupplemented medium with glucose used in the pre-enrichment. 
97 
Production of fumonisins by F. proliferatum in less than 
a month of incubation, and without the need of sophisticated 
equipment might facilitate the production of labeled FB, for 
metabolic studies. In this study, basal salts were used with 
1-methionine and vitamin B supplementation. The ability of F. 
proliferatum to increase fumonisins production in the presence 
of vitamins implies that the fungus requires vitamins. Most 
fungi require thiamin and biotin, and fewer fungi require 
pyridoxamine, while riboflavin, nicotinic acid, pantothenate 
and vitamin B^g required by very few fungi isolated in 
nature (Robinson, 1978). Fusarium proliferatum seem to 
require all of these vitamins in order to synthesize 
fumonisins. F. proliferatum utilizes some of the carbons from 
methionine and the malt extract and seems to prefer the malt 
extract to glucose at early stages of growth. Other carbon 
sources for the fungi are from sucrose and glycerol during the 
later stages of growth. The use of basal salts in combination 
with the nitrogen (from NH^Cl and NH^H^PO^) and carbon sources 
serve as growth enzyme activators and increased rate of 
absorption of the nutrients (Robinson, 1978). The defined 
nature of this medium (basal salts, methionine and vitamins 
Table II) makes it well suited for biosynthetic and 
nutritional requirements of FB production by Fusaria spp. 
This medium could provide a suitable substrate for the 
production of fumonisins using C-14 labelled methionine. 
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Metabolism of fumonisins 
^'•C-labelled FB, was mainly disposed of in the feces (96%) 
with 2.5% excreted in urine. The counts in feces include 
biliary FB, excretion. Some radioactivity was found in the 
liver (0.7%) and to a lesser extent in the kidneys (0.07%) and 
sample of thigh muscle. There was no radioactivity in the 
blood. Based on the number of radioactive counts given to the 
rats and the number of cpm expected, only 4% was absorbed by 
the body. The amount of radioactivity in the GI tract was not 
determined; therefore, they might be part of the unaccounted 
counts. Similar results reported by Shephard et al. (1992a) 
showed that 101% of methionine-labelled FB, was recovered 
in the feces, and only trace amounts were recovered in the 
urine and muscles when 28 /iCi/mmol FB^ was dosed at 7.5 mg/kg 
bodyweight to 6 week old rats. Fumonisin B^ given through 
intraperitoneal injection was found (66%) in the feces, 32% in 
urine, 1% in liver and only trace amounts in kidney and blood. 
A similar study carried out by the same group but using non-
labelled FB^ showed that after i.p. injection, FB^ was absorbed 
rapidly and maximum concentrations were detected in plasma 
within 20 minutes of injection. Sixteen percent of the dose 
of FB^ was recovered intact in feces when the route of 
exposure was through i.p. injection and only 0.4 % was 
recovered in urine when exposure by gavage (Shephard et al., 
1992b). However, a recent review article points out that some 
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groups have recovered the greatest amount of radioactivity in 
the liver and kidney, with small amounts accumulating in these 
organs for at least 96 hours when the rats were dosed orally 
(Riley et al., 1993). Results from our study and Shephard's 
study imply that fumonisins must be highly toxic, because 
almost all the fumonisin seems to be excreted intact in feces 
within 24 hours, and only small amounts are seemingly absorbed 
by the body. 
These conflicting results about the disposition of 
fumonisins indicate the need to produce an efficiently 
labelled pure FB for toxicokinetic studies. 
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Table I: Submerged liquid culture medium used for growing 
Fusarium moniliforme cultures to produce fumonisin B, 
Ingredients^ 
Glucose 
(NHJgSO^ 
KHgPO^ 
MgSO^.THgO 
CaCl2.2H20 
MnSO^ . HjO 
Ingredients^ 
Thiamin 
Riboflavin 
Niacin 
Pyridoxamine 
Thiotic acid 
Folic acid 
Biotin 
Vit 312 
Amount (g/L) 
90.0 
3.5 
2.0 
0.3 
0.4 
0.2 
Amount (uafL) 
500 
500 
500 
500 
500 
50 
50 
50 
Glucose,Thiamin, riboflavin, niacin, pyridoxamine, thiotic 
acid, folic acid, biotin and vit B12 were obtained from 
Sigma Chemical Co. (St. Louis, MO) . (NH^)2S0^, KH^PO^, 
MgSO^.VHjO, CaClg.211,0 and MnSO^.HgO were obtained from 
Fisher Scientific Chemical Co. (Springfield, NJ). 
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Table II: Basal salt medium used for growing cultures of 
fumonisin-producing Fusaria 
Pre-enrichment medium 
Ingredients^ 
(NHJCl 
FeSO^.VHgO 
MgSO^.VHgO 
KH2PO4 
Peptone 
Yeast 
Glucose* 
Amounts (CX/IA) 
3.0 
0 . 2  
2 . 0  
2 . 0  
2 . 0  
2 . 0  
2 0 . 0  
Growth medium 
Ingredients^ 
(NHJgHPO^ 
NaCl 
MgSO^.THjO 
KH2PO4 
Sucrose 
Glycerol 
Amounts fg/L) 
1.0 
5.0 
2 . 0  
3.0 
40.0 
10.0 
* Glucose was substituted with malt extract^ in experiments 2 
and 3. 
1 (NH^)Cl, FeSO^.THgO, MgSO^.VHgO, KHgPO^, (NH,)2HP0^ and NaCl 
were obtained from Fisher Scientific Chemical Co. 
(Springfield, NJ). Glucose was obtained from Sigma 
Chemical Co. (St. Louis, MO). Peptone and yeast extract 
were obtained from Difco Lab (Detroit, MI). 
^ Malt extract was obtained from BBL (Cockeysville, MI) . 
104 
Table III: Gilchrist and Grogan medium adapted to permit 
fumonisins production by F. moniliforme and/or F. 
proliferatum cultures. 
Ingredients^ Amounts fa/100 mL) 
Potato dextrose broth 2.4 
Yeast extract 0.1 
1-methionine 0.25 
^ Potato dextrose broth and yeast extract were obtained from 
Difco Lab. (Detroit, MI). 1-methionine was obtained from 
Gibco Lab (Grand Island, NY). 
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Table IV: Amounts of fumonisin B1 produced by Fusarium 
proliferatum M5991 on basal salt medium (medium 
II) supplemented with vitamins with and without pH 
adjustment and incubated at 22 ± 2 °C for 24 days 
Medium^ Amount of FB^ produced (ua/rah) 
Day 14 Dav 18 Day 24 
Medium II (A) 2 5 ND 
Medium II (B) ND^ 5 10 
Medium II (A) pH adjusted^ 1 ND 3 
Medium II (B) pH adjusted 2 4 6 
^ Medium II (A) is a basal salt medium with glucose used in 
the pre-enrichment medium. 
^ Medium II (B) is a basal salt medium with malt extract 
used in the pre-enrichment medium. Medium II (A) or (B) 
pH adjusted indicate that the pH was adjusted to 5 using 
NaOH or HCl throughout the experiment. 
^ ND means amounts not determined. 
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Table V: Amounts of fumonisin B1 produced by Fusarium 
proliferatum M5991 incubated on basal salt medium 
(medium II) supplemented with 25 mg methionine, 
Gilchrist & Grogan (G & G) medium, at 22 ± 2 °C 
for 24 days 
Medium Amount of FB^ produced (ua/mL) 
Dav 10 Dav 16 Dav 24 
(1) G & G 51.7 70.4 71.0 
(2) G & G +viti 68.2 79.1 79.8 
(3) Medium II 1.9 22.2 ND^ 
(4) Medium 11+ met^ 89.5 230.2 349.0 
^ Gilchrist and Grogan medium #2 was supplemented with 500 
Hg/h each of thiamin, riboflavin, pantothenate, niacin, 
pyridoxamine, and thiotic acid, and 50 /xg/L each of folic 
acid, biotin, and vitamin B12. 
^ Medium II is a basal salt medium which was supplemented 
with 25 mg 1-methionine/ 100 mL of medium, and the B 
vitamins. 
^ ND means amounts not determined. 
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Table VI: Disposition of a single dose (0,1 juCi) methionine L-
[methyl^'^C]-labelled FB, in 3 rats over 24 hrs 
Total 
Sample Rat # Avg. Quenching Corrected Corrected % Dose 
cpm factor' cpm^ cmp' recovered'' 
Feces 1 2007 8.6 17260 50918 95% 
2 2865 8.6 24639 101002 97% 
3 1990 8.6 17111 56462 96% 
Urine 1 226 0.8 181 1898 3.0% 
2 240 0.8 192 2112 2.0% 
3 244 0.8 305 1525 2.6% 
Liver 1 70 1.4 98 578 1.0% 
2 98 1.4 137 768 0.7% 
3 44 1.4 62 316 0.6% 
Kidney 1 23 1.8 41 54 0.1% 
2 27 1.8 49 58 0.1% 
3 13 1.8 24 27 0.05% 
Muscle 1 14 1.6 22 68 0.1% 
2 15 1.6 24 62 0.1% 
3 10 1.6 16 38 0.6% 
Blood 1 1 1 
2 -7 1 No quenching 
3 -3 1 
Quenching = (Average # of cpm in spiked sample (or control)-
factor cpm for the blank) ? (Average # of cpm obtained by 
placing the corresponding amount of 14C-labelled FBI in 
10 mL of scintillation fluid - cpm for the blank) 
Corrected cpm = Average cpm x quenching factor 
Total corresponding cpm = corrected cpm % total amount of sample in g 
or mL 
% dose recovered = 100 x Total corresponding cpm sample ? total 
cpm recovered in all samples for each rat 
Figure 1. Production of fumonisins by Fusarium proliferatum M5991, a predominate 
producer of fumonisin Bl, in a basai sait medium supplemented with vitamins. 
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Figure 2. Production of fumonisins by Fusarium proliferatum M6104, a predominate 
producer of fumonisin B3, in a basal salt medium supplemented with vitamins. 
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Figure 3. Production of fumonisins by Fusarium proliferatum M6290, a predominate 
producer of fumonisin B^, in a basai sait medium supplemented with vitamins. 
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GENERAL CONCLUSIONS 
Feeding of Fusarium proliferatum-fermented corn culture 
material containing 20 or 50 ppm FB^ for 6 months induced 
liver cancer in female F344/N rats. Placental glutathione S-
transferase (PGST) proved to be a better marker of altered 
hepatic foci (AHF) than 7-glutamyltransferase (GGT) in that 
only PGST-(+) AHF were noted when a single dose of 
diethylnitrosamine (DEN, 30 mg/kg body weight), a very mild 
initiating stimulus was administered to rats. The persistence 
of PGST-(+) AHF also imply that this marker is more reliable 
than GGT in examining FB^ carcinogenesis at small amounts of 
exposure. Future research is necessary in determining if PGST 
is also a stable marker of FB^-induced hepatocarcinogenicity 
in male and females using purified FB,. 
These studies also showed that FB is fetotoxic, therefore 
it is potentially teratogenic. The metabolism studies showed 
that FB^ is rapidly excreted almost entirely in feces, and 
only a small amount is absorbed in the body (4%). These 
results raise other issues concerning the minimum exposure 
level (dose) of fumonisins, given that only a small amount is 
absorbed in the body. Specifically, is the proposed mechanism 
of alteration of sphigolipid metabolism by fumonisins critical 
in cancer induction, fetotoxicity and other toxic effects 
caused by fumonisins or is there another mechanism? The 
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proposed role of fumonisins in sphingolipid metabolism is of 
importance and needs to be addressed further in future 
research as to what dose of FB alter the sphingolipid 
metabolism, and the relationship between the alteration of the 
sphingoid base ratios and FB toxicity. 
In this study, it was shown that the biosynthesis of 
fumonisins from F. proliferatum cultures requires nutrient 
supplementation beyond the basal salts and carbohydrate 
source. Supplementing the medium with 25 mg 1-methionine/lOO 
mL medium improved the production of fumonisins tremendously, 
showing a 10 fold increase of FB,, and a 430 and 23 fold 
increase in FBg and FBj, respectively. In the presence of 
methionine production of fumonisins Bg and B^ was not delayed; 
in contrast to when the basal salt was without methionine. 
The medium without methionine produced the highest 
concentrations (0.2 jug/mL) FBj or (0.45 ng/vxL) FB3 after day 32 
and 3 6 of incubation, respectively. This study could provide 
a useful basis for subsequently determining whether FBg and FB3 
are byproducts of FB, or are synthesized independently. 
116 
LITERATURE CITED 
Abbas HK, Mirocha CJ, Vesonder RF, Gunther R (1990): Acute 
toxic effects of an isolate of itipniliformin-producing Fusarium 
oxysporum and purified moniliformin on rats. Arch Environ 
Contain Toxicol 19:433-436. 
Abbas HK, Gelderbloiti WCA, Cawood ME, Shier WT (1993): 
Biological activities of fumonisins, mycotoxins from Fusarium 
moniliforme, in jimsonweed {Datura stramonium L) and mammalian 
cell cultures. Toxicon 31:345-353. 
Abramovici A (1977): Mycotoxins and abnormal fetsl 
development. Cotri Microbiol Immunol 3:81-94. 
Arora RG, Frolen H, Nilsson A (1981): Interference of 
mycotoxins with prenatal development of the mouse. I. 
Influence of aflatoxin Bl, ochratoxin A and zearalenone. Acte 
Vet Scand 22:524-534. 
Arora RG, Frolen H (1981): Interference of mycotoxins with 
prenatal development of the mouse. II. Ochratoxin A induced 
teratogenic effects in relation to the dose and the stage of 
gestation. Acta Vet Scand 22:535-552. 
Bacon CW, Williamson JW (1992): Interaction of Fusarium 
moniliforme, its metabolites and bacteria with corn. 
Mycopathologia 117:65-71. 
Bannasch P, Enzmann H, Klimek F, Weber E, Zerban H (1989): 
Significance of sequential cellular changes inside and outside 
foci of altered hepatocytes during carcinogenesis. Toxicol 
Pathol 17:617-628. 
Bezuidenhout Sc, Gelderblom WCA, Gorst-Allman CP, Horak RM, 
marasas WFO, Spiteller G, Vleggaar R (1988): Structure 
elucidation of fumonisins, mycotoxins from Fusarium 
moniliforme. J Chem Soc Chem commun 1988:743-745. 
Borek C, Ong A, Stevens VL, Wang E, Merrill AH (1991): Long-
chain (sphigoid) bases inhibit multistage carcinogenesis in 
the mouse C3H/10T1/2 cells treated with radiation and phorbol 
12-myristate 13-acetate. Proc Natl Acad Sci USA 88:1953-1957. 
Boutwell RK (1974): The function and mechanism of promoters of 
carcinogenesis. CRC Crit Rev Toxicol 2:419-443. 
Brown TP, Rottinghaus GE, William ME (1992): Fumonisin 
mycotoxicosis in broilers: performance and pathology. Avian 
117 
Dis 36:450-454. 
Campbell HA, Pitot HC, Potter VR, Laishes BA (1982) : 
Application of quantitative stereology to the evaluation of 
enzyme-altered foci in rat liver. Cancer Res 42:465-472. 
CAST (Council for Agricultural Science and Technology) (1989): 
Mycotoxins, Economic and Health risks. Task force report # 
116. 
Cawood ME, Gelderblom WCA, Vleggar R, Behrend Y, Thiel PG, 
Marasas WFO (1991); Isolation of the fumonisin mycotoxins: A 
quantitative approach. J Agric Food Chem 39:1958-1962. 
Chen J, Mirocha CJ, Xie W, Hogge L, Olson D (1992): Production 
of the mycotoxin fumonisin B^, by alternaria alternata f.sp. 
lycopersici. Appl. Env. Microbiol. 58:3928-3931. 
Colvin BM, Cooley AJ, Beaver RW (1993): Fumonisin toxicosis 
in swine: clinical and pathological findings. J vet Diagn 
Invest 5:232-241. 
Delm E, Oesterle D 1982): Sex-dependent promoting effect of 
polychlorinated biphenyls on enzyme-altered islands induced by 
diethylnitrosamines in rta liver. Carconogenesis 3:1449-1453. 
Di Paolo JA, Kotin P (1966): Teratogenesis and oncogeneis: a 
study of possible relationship. Arch Pathol 81:3-23. 
Emmelot P, Scherer E (1980): The first relevant, cell stage in 
liver rat carcinogenesis - a quantitative approach. Biochim 
Biophys Acta 605:247-304. 
Eustis SL, Boorman GA, Harada T, Popp JA (1990): Liver. In 
Pathology of the Fisher Rat. eds. Boorman GA, Eustis SL, 
Elwell MR, Montgomery Jr CA, Mackenzie WF. Academic Press, San 
Diego, CA. 
Farber E (1973): Carcinogenesis - Cellular evolution as a 
unifying thread: Presidential address. Cancer Res 33:2537-
2550. 
Farber E (1980): The sequential analysis of liver cancer 
induction. Biochim Biophys Acta 605:149-166. 
Farber E (1984): Cellular biochemistry of the stepwise 
development of cancer with chemicals. Cancer Res 44:5463-5474. 
Fincham JE, Marasas WFO, Taljaard JJF, Kriek NPJ, Badenhorst 
CJ, Gelderblom WCA, Seier JV, Smuts CM, Farber M, Weight MJ, 
118 
Slanzs W, Woodroof CW, van Wyk MJ, Kruger M, Thiel PG (1992): 
Artherogenic effects in a non-human primate of Fusarium 
moniliforme cultures added to carbihydrate diet. 
Atherosclerosis 94:13-15. 
Gerber MA, Thung SN (1980): Enzyme patterns in human 
hepatocellular cancer. Am J Pathol 98:395-400. 
Gelderblom WCA, Thiel PG, Jaskiewicz K, Marasas WFO (1986): 
Investigations on the occurrence of Fus C, a mutagen produced 
by Fusarium moniliforme, in corn. J Agri Food Chem 32:1064-
1067. 
Gelderblom WCA, Marasas WFO, Jaskiewicz K, Combrinck S, van 
Schalkwyk DJ (1988a): Cancer promoting potential of different 
strains of Fusarium moniliforme in a short-term cancer 
initiation/promotion assay. Carcinogenesis 9:1405-1409. 
Gelderblom WCA, Thiel PG, van der Merwe KJ (1988b): The role 
of rat liver microsomal enzymes in the metabolism of the 
fungal metabolite Fusarin C. Fd Chem Toxicol 26:31-36. 
Gelderblom WCA, Marasas WFO, Thiel PG, Semple E, Farber E 
(1989): Possible non-genotoxic effects of native carcinogenic 
components produced by fusarium moniliforme. Proc Am Ass 
Cancer Res 30:144-
Gelderblom WCA, Kriek NPJ, Marasas WFO, Thiel PG (1991): 
Toxicity and carcinogenicity of the Fusarium moniliforme . 
metabolite, fumonisin , in rats. Carcinogenesis 12:1247-
1251. 
Gelderblom WCA, Snyman SD (1991): Mutagenicity of potential 
carcinogenic mycotoxins produced by Fusarium moniliforme. 
Mycotoxin Res 7:47-52. 
Gelderblom WCA, Semple E, Marasas WFO, Farber E (1992); The 
cacer intiating potential of fumonisin mycotoxins. 
Carcinogenesis 13:433-437. 
Gelderblom WCA, Cawood ME, Snyman SD, Vleggar R, Marasas WFO 
(1993): Structure-activity relationship of fumonisins... Fd 
Chem Toxic 31:407-414. 
Glauert HP, Pitot HC (1986): Influence of dietary fat on the 
promotion of diethylnitrosamine-induced hepatocarcinogenesis 
in female rats (42283) . Proc Society for Exp Biol Med 
181:498-506. 
Goldsworthy TL, Pitot HC (1985): The quantitative analysis and 
119 
stability of histochemical markers of altered hepatic foci in 
the rat liver following initiation by diethylnitrosamine 
administration and promotion with phénobarbital. 
Carcinogenesis 6:1261-1269. 
Goldsworthy TL, Hanigan HM, Bitot HC (1986); Models of 
hepatocarcinogenesis in rats - contrasts and comparisons. CRC 
Crit Rev Toxicol 17:61-89. 
Hansen TJ (1993): Quantitative testing for mycotoxins. CFW 
38:346-348. 
Hansen LA, Monteriro-Riviere NA, Smart RC (1990): Differential 
down-regulation of epidermal protein kinase C by 12-0-
tetradecanoylphorbol-13-acetate and diacylglycerol: 
association with epidermal hyperplasia and tumor promotion. 
Cancer Res 50:5740-5745. 
Hayes WA (1981): Mycotoxins and abnormal fetal development. 
In Myxotoxins Teratogenicity and Mutagenicity . Hayes AW (ed). 
CRC Press Inc. Boca Rotan, Fl. pp 41-66. 
Hendrich S, Glauert HP, Pitot HC (1986): The phenotypic 
stability of the altered hepatic foci: effects of withdrawal 
and subsequent readministration of phénobarbital. 
Carcinogenesis 7:2941-2045. 
Hendrich S, Pitot HC (1987): Enzymes of glutathione metabolism 
as biochemical markers during hepatocarcinogenesis. Ca Metast 
Rev 6:155-178. 
Hendrich S, Miller KA, Wilson TM, Murphy PA (1993): The 
toxicity of fumonisins in nixtamilized corn-based diets fed 
rats: effect of the nutritional status. J Agric Food Chem 
(submitted). 
Hopmans E, Murphy PA (1993): Detection of fumonisins B^, Bg, 
and Bj and htdrolyzed fumonisin B^ in corn containing foods. J 
Agri Food Chem (submitted). 
Iversen HO (1988): Initiation, promotion: Critical remarks on 
the two stage theory. In Theories of Carcinogenesis. 
Hemisspher Pub. Co. Washington DC 
Jackson MA, Bennett GA (1990): Porduction of FB^ by fusarium 
moniliforme NRRL 13616 in submerged culture. Appl Env 
Microbiol 56:2296-2298. 
Johnson M (1965): Nutritional factors in mammalian teratology: 
In Teratology - Principles and Techniques. JG Wilson, J 
120 
Warkany (eds). University Press, Chicago II. ppll3-123. 
Kellerman TS, Marasas WFO, Thiel PG, Gelderblom WCA, Cawood M, 
Coetzer JAW (1990): Leukoencephalomalacia in two horses 
induced by oral dosin of fumonisin B,. Ondertepoort J vet Res 
57:269-275. 
Kitahara A, Satoh K, Sato K (1983); Properties of increased 
GST A form if rat preneoplastic hepatic lesions induced by 
chemical carcinogens. Biochim Biophys Res Comm 112:20-28. 
Kraus GA, Applegate JM, Reynolds D (1992): Synthesis of 
anologs of fumonisin Bl. J Agri Food Chem 40:2331-2332. 
Lu S-J, Ronai ZA, Li MH, Jeffrey AM (1988): Fusarium 
monlliforme metabolites; genotoxicity of culture extracts. 
Carcinogenesis 9:1523-1527. 
Marasas WFO, Thiel PG, Rabie CJ, Nelson PE, Toussoun TA 
(1986): Moniliformin production in Fusarium section Liseola. 
Mycologia 78:242-247. 
Marasas WFO, Nelson PE (1987): Mycotoxicology. Pennsylavania 
State Univ Press, University Park, Pennsylavania. 
Marasas WFO, Kellerman TS, Gelderblom WCA, Coetzer JAW, Thiel 
PG, van der Lugt JJ (1988): Leucoencephalomalacia in a horse 
induced by fumonisin Bl isolated from Fusarium monlliforme. 
Onderstepooort J Vet Res 55:197-203. 
Miller EC, Miller JA (1981): Mechanisms of chemical 
carcinogenesis. Cancer 47:1055-1064. 
Mitaka T, Tsukada H (1987): Sexaul difference in the 
histochemical charactrestics of "altered cell foci" in the 
liver of aged Fisher 344 rats. Jpn J Cancer Res (Gann) 
78,*785-790. 
Moore MA, Nakagawa K, Satoh K, Ishikawa T, Sato K (1987): 
Single GST-P positive liver cells - putative initiated 
hepatocytes. Carcinogenesis 8:483-486. 
Morris RW (1989): Testing statistical hypotheses about rat 
liver foci. Toxicol Pathol 17:569-578. 
Murphy PA, Rice LG, Ross PF (1993): Fumonisins Bl, B2 and B3 
content in Iowa, Wisconsin and Illinois corn and screenings. 
J Agri Fd Chem 41:263-265. 
Nelson PE, Plattner RD, Shackelford DD, Desjardins AE (1991): 
121 
Production of fumonisins by Fusarium moniliforme strains from 
various subtrates and geographic areas. Appl Environ 
Microbiol 57:2410-2412. 
Nelson PE (1992): Taxonomy and biology of Fusarium 
moniliforme. Mycopathol 117:29-36. 
Norred WP (1993): Fumonisins - mycotoxins produced by 
Fusarium moniliforme. J Toxicol Environ Health 38:309-328. 
Osweiler GD, Ross PF, Wilson TM, Nelson PE, Witte ST, carson 
TL, Rice LG, nelson HA (1992): Characteristics of an 
epizootic of pulmonary edema in swine associated with 
fumonisinin corn screenings. J vet diagn Invest 4:53-59. 
Peraino C, Staffeldt EF, Carnes BA, Ludeman VA, Blomquist JA, 
Vesselinovitch SD (1984): Characterization of histochemically 
detectable altered hepatocyte foci and their relationship to 
hepatc tumorigenesis in rats treated once with 
diethylnitrosamine or benzo(a)pyrene within one day after 
birth. Cancer Res 44:3340-3347. 
Peraino C, Staffeldt EF, Ludeman VA (1981): Early appearance 
of histochemically altered hepatocyte foci and liver tumors in 
female rats treated with carcinogens one day after birth. 
Carcinogenesis 2:463-465. 
Plattner RD, Shackelford DD (1992): Biosynthesis of labeled 
fumonisins in liquid cultures of Fusarium moniliforme. 
Mycopathologia 117:17-22. 
Plattner RD, Weiseleder D, Shakelford DD, Peterson R, Powell 
RG (1992): A new fumonisin from solid cultures of Fusarium 
moniliforme. Mycopathologia 117:23-28. 
Pitot HC (1977) : The natural history of neoplasia. Am J 
Pathol 89:402-411. 
Pitot HC, Barsness L, Goldsworthy T, Kitagawa T (1978): 
Biochemical characterisation of stages of hepatocarcinogenesis 
after a single dose of diethylnitrosamine. Nature 271:456-
457. 
Pitot HC, Sirica AE (1980) : The stages of initiation and 
promotion in hepatocarcinogenesis. Biochim Biophys Acta 
605:191-215. 
Pitot HC, Goldsworthy TL, Moran S, Kennan W, Glauert HP, 
Maronpot RR, Campbell HA (1987): A method to quantitate the 
relative initiating and promoting potencies of 
122 
hepatocarcinogenic agents in their dose-response relationships 
to altered hepatic foci. Carcinogenesis 8:1491-1499. 
Pitot HC, Beer DG, Hendrich S (1988): Multistage 
carcinogenesis: The phenomenon undelying the theories. In 
Theories of carcinogenesis, ed. OH Iversen. Hemisphere Pub 
Corp. Washington pp. 159-177. 
Pitot HC (1990): Altered hepatic foci: Their role in murine 
hepatocarcinogenesis. Annul Rev Pharmacol Toxicol 30:465-500. 
Popp JA, Goldsworthy TL (1989): Defining foci of cellular 
alteration in short-term and medium-term rat liver tumor 
models. Toxicol Pathol 17:561-568. 
Rabes HM, Scholze P, Jantsch B (1972): Growth kinetics of 
diethylnitrosamine-induced, enzyme-deficient "preneoplastic" 
liver cell populations in vivo and in vitro. Cancer Res 
32:2577-2586. 
Rheeder JP, Marasas WFO, Thiel PG, Sydenham EW, Shephard GS, 
van Schalkwyk DJ (1992): Fusarium moniliforme and fumonisinss 
in corn in relation to human esophageal cancer in Transkei. 
Am Phytopathol Soc 82:353-357. 
Riley RT, An N-Y, Showker JL, Yoo H-S, Norred WP (1993): 
Alteration of tissue and serum sphingasine and sphingosine 
ratio: An early biomarker in pigs exposure to fumonisin-
containing feeds. Toxicol Appl Pharmacol 118:105-112. 
Roomi MW, Ho RK, Sarma SR, Farber E (1985): A common 
biochemical pattern in four different models in rat. Cancer 
Res 45:564-571. 
Ross PF, Nelson PE, Richard JL, Osweiler GD, Rice LG, Plattner 
RD, Wilson TM (1990): Production of fumonisins by Fusarium 
moniliforme and Fusarium proliferatum isolates associated with 
equine leukoencephalomalacia and pulmonary edema sydrome in 
swine. Appl Environ Microbiol 56:3225-3226. 
Sargeant K, Sheridan A, O'kelly J, Carnahan RBA (1961): 
Toxicity associated wiyh samples of groundnuts. Nature 
(London) 192:1096-2004. 
Sasaki T, Yoshida T (1935): Experimental induction of 
hepatocarcinoma by feeding with o-aminoazotoluene. Virchows 
Arch 295:175-200. 
Sato K, Kitahara A, Satoh K, Ishikawa T, tatematsu M, Ito N 
(1984): The placental form of glutathione S-transferase as a 
123 
new marker protein for preneoplasia in rat chemical 
hepatocarcinogenesis. Gann 75:199-202. 
Sawabu N, Nakagen M, Ozaki K, Wakabayashi T, Toya D, Hator N, 
Ishii M (1983): Clinical evaluation of specific gamma glutamyl 
transpeptidase isoenzyme in patients with hepatocellular 
cancer. Cancer 51:327-331. 
Scherer EP, Emmelot B (1975): Foci of altered liver cells 
induced by one dose of dimethylnitrosamine and partial 
hepatectomy: Their contribution to hepatocarcinogeniesis in 
rat. Europ J Cancer 11:145-154. 
Schimdt RE, Panciera RJ (1980): Effects of aflatoxins on 
pregnabt hamsters and hamster foetuses. Comp Pathol 90:339-
347. 
Schulte-Hermann R, Kraup-Grasl B, Burch W, Gerbracht U, 
Timmermann-Trosiener I (1989): Effects of non-genetoxic 
hepatocarcinogens, phénobarbital and nafenopin on phenotype 
and growth of different population of altered foci in rat 
liver. Toxicol Pathol 117:642-649. 
Shephard GS. Thiel PG, Sydenham EW (1992): Fate of a single 
dose of the '^C-labelled mycotoxin, fumonisin in rats. Food 
Chem Toxicol 30:768-770. 
Shier WT (1993): Sphingosine analogs: An emerging new class 
of toxins that includes the fumoninsins. J Toxicol - Toxin Rev 
11:241-257. 
Solt DB, Farber E (1976): New principle for the analysis of 
chemical carcinogenesis. Nature 263:701-703. 
Squire RA, Levitt MH (1975): Report of a workshop on 
classification of specific hepatocellular lesions in rats. 
Cancer Res. 35:3214-3223. 
Stark A-A (1980): Mutagenicity and carcinogenicity of 
mycotoxins: DNA binding as possible mode of action. Ann Rev 
Microbilo 34:235-262. 
Sydenham EW, Thiel PG, Marasas WFO, Shephard GS, Van Schalkwyk 
DJ, Koch KR (1990): Natural occurrence of some Fusarium 
mycotoxins in corn from low and high esophageal cancer 
prevalence areas of the Transkei, Southern Africa. J Agric 
Food Chem 38:1900-1903. 
Sydenham EW, Shephard GS, Thiel PG, Marasas WFO, Nelson PE, 
Wilson TM (1991): Fumonisin contamination of commercial corn-
124 
based human foodstuffs. J. Agri. Food Chem. 38:1900-1903. 
Tatematsu M, Mera Y, Inoue T, Satoh K, Sato K, Ito N (1988): 
Stable phenotypic expression of glutathione S-transferase 
placental type and unstable phenotypic expression of gamma-
glutamyltransferase in rat liver preneoplastic and 
neoplastic lesions. Carcinogenesis 9:215-220. 
Thiel PG, Gelderblom WCA, Marasas WFO, Nelson PE, Wilson TM 
(1986): Natural occurence of moniliformin and fusarin in corn 
screenings known to be hepatocarcinogenic in rats. J Agri Fd 
Chem 34:773-775. 
Thiel PG, Marasas WFO, Sydenham EW, Shephard GS, Gelderblom 
WCA, Nieuwenhuis JJ (1991a): Survey of Fumonisin production by 
Fusarium species. Appl Environ Microbiol 57:1089-1093. 
Thiel PG, Sherphard GS, Sydenham EW, Marasas WFO, Nelson PE, 
Wilson TM (1991b) : Levels of fumonisin and FBg in feeds 
associated with confirmed cases of equine 
leukoencephalomalacia. J Agric food Chem 39:109-111. 
Thiel PG, marasas WFO, Sydenham EW, Shephard GS, Gelderblom 
WCA (1992): The implications of naturally occuring levels of 
fumonisins on corn for human and animal health. 
Mycopathologia 117:3-9. 
Voss KA, Plattner RD, Bacon CW (1989): Hepatotoxicity and 
renal toxicity in rats of corn samples associated with field 
cases of equine leukoencephalomalacia. Food Chem Toxicol 
27:89-96. 
Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH Jr (1991): 
Inhibitionof sphingolipid biosythesis by fumonisins: 
Implications for disease associated with Fv.sarium moniliforme. 
J Biol Chem 266:14486-14490. 
Wang E, Ross PF, Wilson TM, Riley RT, Merrill AH Jr (1992): 
Alteration of serum sphingolipids upon exposure of ponies to 
feed containing fumonisins, mycotoxins produced by Fusarium 
moniliforme. J Nutr 122:1706-1716. 
Ward JM (1983): Background data and variations in tumor rates 
of control rats and mice. Prog Exp Tumor Res 26:241-258. 
Weibking TS, LeDoux DR, Bermudez AJ, Turk JR, Rottinghaus GE, 
Wang E, Merrill AH Jr (1993): Effects of feeding Fusarium 
moniliforme culture material containing known levels of 
fumonisin B^, on the young broiler chicks. Poultry Sci 
72:456—466. 
125 
Wiebe LA, Bjeldanes LF (1981); Fusarin C, a mutagen from 
Fusarium moniliforme growing on corn. J Food Sci. 46:1424-
1426. 
Weinstein B (1988); The origins of human cancer; molecular 
mechanism of carcinogens and their implications for cancer 
prevention and treatment. G, H. A. Memorial Lecture. Cancer 
Res 48:4135-4143. 
Williams GM (1980): The pathogenesis of rat liver cancer 
caused by chemical carcinogens. Biochim Biophys Acta 605:167 
189. 
Wilson BJ (1982); Mycotoxins and toxic stress metabolites of 
fungus. In Nutritional toxicology. JN Hathcock (ed). Academic 
Press. New York. pp239 - 306. 
Xu Y, Campbell HA, Satter GL, Hendrich S, Maropot R, Sato K, 
Pitot HC (1990): Quantitative stereological analysis of the 
effects of age and sex on multistage hepatocarcinogenesis in 
the rat by use of four cytochemical markers. Cancer Res 
50:471-479. 
Yoshida T (1932): Uber die experimentelle erseugung von 
hepatomen durch die futterung mit o-aminoazotuluol. Proc Imp 
Acad Jpn 8:464-467. 
126 
ACKNOWLEDGEMENTS 
My special thanks goes to Dr. Suzanne Hendrich under 
whose supervison this work was planned and carried out. I 
value your constructive critisms and guidance, and especially 
your patience. My heartfelt gratitude goes to Dr. Terrance 
Wilson and Dr. Harpal Bal who helped with the pathology and 
teratogenecity aspect of this study. 
I am immensely grateful to Dr. Patricia Murphy in whose 
laboratory the fumonisins were extracted and purified. My 
heartfelt gratitude goes to Ellen Hopmans who extracted and 
purified the fumonisins used in this study. Larry Rice's 
expedient help deserves a special thanks in analyzing the 
amounts of fumonisins in the liquid cultures. 
No words would be adequate to thank my husband and son 
for putting up with me through these hectic times, for the 
love and encouragement they gave me, I will forever be 
grateful. To my two little girls, thanks for the 
"understanding" you showed when mommy could not be with you 
most of the time. 
I am heartily thankful to my dear friend Bawk for being 
available to my little girls to offer them the motherly love. 
To my mother, under whose discipline and encouragement has 
contributed has contributed in no small measure to the making 
of the person I am today. 
